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Abstract
The ribosome is the molecular machine which reads and translates genetic information into proteins
in all living cells. Lack of an atomic-resolution structure of the ribosome in its actual functional states
prevents our understanding of the ribosome. A hybrid approach overcomes the challenge by combining
experimental data from X-ray crystallography and cryo-electron microscopy with computing, permit-
ting one to resolve atomic-level structures of intermediates of the functional ribosome and, thereby,
to advance our understanding of ribosome function and the underlying physical mechanisms. In this
thesis works we further developed an existing hybrid approach, namely the molecular dynamics flexi-
ble fitting (MDFF) method, and apply it to the ribosome. We improved MDFF in two regards, first
by incorporating structural symmetry information into the fitting protocol and second by the use of a
so-called implicit solvent model. In pursuit of the needed methodological development we participated
in the Cryo-EM Modeling Challenge 2010, competing with the MDFF method against other hybrid
methods. Two aspects of ribosomal functions were investigated. First we studied bacterial resistance
to the antibiotic tetracycline, a study that involved a detail investigation of processes in the ribosome.
Second we employed MDFF and molecular dynamics simulations to characterize the dynamics of a
ribosome-bound chaperone, called trigger factor.
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Chapter 1
Introduction
In all living cells, proteins are synthesized by a molecular machine called the ribosome which reads
the genetic information stored on messenger RNA (mRNA) and translates it into protein chains. The
ribosome is composed of over 50 different interacting molecular components, including both proteins
and RNAs, which assemble into two subunits, namely the large and the small subunit (Fig. 1.1).
Figure 1.1: Structure of a translating ribosome. The small
and large subunits are colored yellow and cyan, respectively,
with tRNA colored orange. The elongating nascent chain
(green) migrates through the exit tunnel to reach the ribo-
somal surface. For ribosome synthesizing a cytosolic protein
chain, a protein called trigger factor (blue) is recruited to
protect the nascent chain from misfolding.
The two subunits work cooperatively in the
translation process, with the small subunit de-
coding the genetic code on mRNA and the large
subunit elongating the nascent protein chain ac-
cording to the genetic information read evoking
the action of a transfer RNA (tRNA) that car-
ries the next amino acid. Besides the ribosomal
proteins and RNAs, the ribosome also recruits
various factors and ligands to accomplish differ-
ent tasks during translation. Moreover, protein
synthesis is carried out in a series of stages in
which the ribosome adopts different conforma-
tions. The variability in constituents and con-
formations possessed by the ribosome renders it
one of the most complex biomolecular systems in
living cells. Taking advantage of the conserved
difference between bacterial and eukaryotic ribo-
somes, over 50% of efforts developing antibiotics
target bacterial ribosomes [1]. Due to its funda-
mental role in living cells and its medical importance, a better understanding of ribosomal functions
is indispensable.
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High resolution structural data is crucial to the study of all biomolecular systems, including the
ribosome. However, the complexity of ribosomal systems poses a huge challenge to structure determi-
nation of the ribosome. An X-ray crystal structure of a full ribosome is available since the last decade.
Yet, many of the conformations adopted by the ribosome during elongation of a protein still fail to
be crystallized. In particular conformations in which the ribosome forms a complex with factors and
ligands are extremely challenging for crystallographic study. Moreover, non-physiological crystalline
conditions sometimes render the ribosome non-functional, decreasing the value of such crystal struc-
tures. On the other hand, one popular approach to determine structures of the ribosomal complex
is cryo-electron microscopy (cryo-EM). In cryo-EM experiments, thousands of samples of the system
of interest are frozen instantaneously, keeping the samples in functional form when they are being
imaged by the electron microscope. A 3-dimensional structure of the system, in the form of a density
map, can be reconstructed from the thousands of images of the samples. Obviating the need of crys-
tallization, cryo-EM has been successfully employed to image ribosomal complexes in different stages
of protein synthesis [2]. However, even though EM maps of ribosomal systems at sub-nanometer res-
olution can be obtained routinely nowadays (5 A˚ to 10 A˚ ), atomic resolution is still not achieved and
direct designation of atomic coordinates into density maps is impossible. Hence, neither the X-ray nor
the cryo-EM approach alone can furnish atomic models of various functional forms of the ribosome.
Fortunately, a computational method comes to rescue by offering a so-called hybrid approach which
bridges the resolution gap between X-ray crystallography and cryo-EM by combining both sources
of experimental data to obtain atomic models of ribosomal complexes at various conformations cap-
tured by cryo-EM. These atomic models provide the structural information necessary for revealing
the mechanisms underlying ribosomal function and for the development of new ribosomal antibiotics
to fight bacterial resistance to antibiotics, a major health threat today.
In this thesis we further developed a hybrid method, namely the molecular dynamics flexible fitting
(MDFF) method [3, 4] and apply it to the ribosome. First, we incorporated structural symmetry
information into the MDFF protocol to enhance the quality of fitted models for symmetric molecular
complexes [5]. Second, we showcased the benefits of using a so-called implicit solvent model for
MDFF [6]. The performance of MDFF was then evaluated against other hybrid methods in the
Cryo-EM Modeling Challenge 2010 [7]. Finally, we applied MDFF to study two ribosomal systems.
We employed MDFF to analyze a cryo-EM structure of the ribosome in complex with a ribosomal
protection protein Tet(O) and revealed the mechanism of bacterial resistance to the tetracycline
antibiotic [8]. We then investigated the dynamics of a ribosome-bound chaperone, called trigger
2
factor, by MDFF and molecular dynamics simulations [9].
1.1 Molecular dynamics simulations and the molecular
dynamics flexible fitting (MDFF) method
Figure 1.2: Bonded energy terms in MD force field
illustrated with a glycine amino acid.
The MDFF method [3] is based on MD simulation. In
MD simulations, atoms are treated as point particles
with different intrinsic properties such as charge, ra-
dius, mass, etc. which affect their interactions with
the surrounding atoms during the simulations. Inter-
actions among atoms are governed by the potential
energy of the system, which usually takes the form of
Eq. 1.1 in standard MD force fields. The force field
is based on chemical knowledge of inter atomic inter-
actions found in biomolecules. The first three terms
describe the interaction energy of atoms involved in
chemical bonds and the last two describe the interac-
tion energy of atoms not directly involved in chemical
bonds. The bond term refers to energy arising in covalent bonds in the system. The angle term
refers to energy arising from angles between pairs of covalent bonds which share an atom as vertex.
The dihedral term refers to energy arising from torsion angles of bonds which connect with two other
bonds at both ends. The dihedral term also includes the so-called “improper” energy which arises
from the planar or non-planar conformation formed by four covalently bonded atoms. The bonded
energy terms are illustrated in Fig. 1.2. The non-bonded energy terms include a term for van der
Waals interaction, which is represented by Lennard-Jones 6-12 potentials, and a term for Coulomb
interactions. Altogether, the potential energy of the biomolecule is given by the expression:
UMD(
−→
R ) =
∑
bond
kbondi (ri − r0)2 +
∑
angles
kanglei (θi − θ0)2 +
∑
dihedrals
kdihedrali [1 + cos(niφi + δi)]
+
∑
i
∑
j>i
4εij [(
σij
rij
)12 − (σij
rij
)6] +
∑
i
∑
j>i
qiqj
4piε0rij
(1.1)
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Here the functional form is chosen to be extremely simple for the sake of fast computation, but this
choice comes at the price of limited accuracy.
Using the above potential energy function, the forces acting on atoms can be evaluated. Together
with the initial positions and velocities, the trajectories of all atoms and, hence, the dynamics of the
simulated system, can be traced. With the advancement in parallel computing and supercomputing
facilities, MD simulations of systems as large as a ribosome (about 300,000 atoms) are now achievable,
allowing us to study the ribosome by MD simulations as well as applying the MD-based MDFF method.
Figure 1.3: Workflow of MDFF.
To employ MDFF, an initial atomic structure, usually an X-ray crystal structure, is subjected
to an MD simulation. In this simulation, two additional energy terms are added to the standard
MD force field potential UMD. The first term, UEM, is derived from the EM density and is used
to apply forces proportional to the gradient of the density map to the atoms using the grid force
feature [10] of NAMD [11]. These forces drive the model towards high density regions of the EM map
and, hence, effectively guide the structure to a conformational state represented by the EM density
(Fig. 1.3). The stereochemical correctness of the structure is ensured by the standard MD force field.
In addition, a second term, USS, which preserves the secondary structure of the system by imposing
harmonic restraints on specific dihedral angles and distances between base pairs, is included to avoid
overfitting, i.e., to avoid unphysical distortions caused by the UEM term when a structure is too closely
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fitted to the EM map. MDFF has already been applied successfully to several ribosomal systems as
reported in [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 8].
1.2 Methodological development of MDFF
1.2.1 Symmetry-restrained MDFF
Figure 1.4: Figure illustrating the idea of symmetry-restrained MDFF. Using the symmetry information extracted from
EM data (top left), atomic model of a symmetric complex (right) can be built from a single protein unit (bottom left) by
symmetry-restrained MDFF. The system shown is a nitrilase from Rhodococcus rhodochrous J1 which is a long helical
complex.
The quality of MDFF models depends heavily on the resolution of the EM map. A lower resolution
map does not represent as much information as a higher resolution map and, hence, the accuracy of
a structure fitted to a low-resolution map is limited. Additional knowledge about the structure,
such as structural symmetry, can be incorporated into the fitting protocol to reduce the number
of available degrees of freedom in the fitting simulations and, hence, improve the quality of fitted
models [26, 5]. Indeed, symmetric averaging is often used to improve the signal-to-noise ratio of
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an EM dataset [27, 28, 29]. An extension of MDFF, symmetry-restrained MDFF, was developed
in which the symmetry information extracted from EM data is incorporated into MDFF (Fig. 1.4).
Implementation and benefits of symmetry-restrained MDFF are described in Chapter 2 and were
published in [5].
1.2.2 MDFF with implicit solvent model
Similar to normal MD simulations, MDFF requires an accurate solvent model [30, 31] to produce
high quality fitted structures. Indeed, many shortcomings of MDFF are largely due to the use of in
vacuo simulations, in which the solvent environment is represented by a single dielectric constant,
omitting many effects of the solvent. On the other hand, explicit solvent model [32] represents the
solvent environment by explicit water molecules, and is regarded as accurate and natural for MD
simulations. However, the inclusion of explicit water molecules largely increases the atom count of a
simulation, often by a factor of ten, rendering MDFF with explicit solvent model computationally too
expensive. The generalized Born implicit solvent (GBIS) model implemented in NAMD [11, 6, 33]
offers a great further advance to the MDFF method by furnishing the necessary description of solvent
environment while avoiding inclusion of a huge number of water molecules into MDFF simulations.
The absence of explicit water molecules also eliminates the viscosity imposed on simulated solutes,
effectively allowing faster equilibration of solute conformations and better conformational sampling
and, hence, speeding up conformational changes in MDFF simulations. The benefits of employing the
GBIS model in MDFF are described in Chapter 3 and were published in [6].
1.2.3 Cryo-EM Modeling Challenge 2010
Besides MDFF, there are many other hybrid approaches which adopt different algorithms to perform
flexible fitting. As a first effort to bring cryo-EM modelers together to evaluate the performance of
various hybrid approaches in a systematic way, the Cryo-EM Modeling Challenge 2010 was held in
which developers of different hybrid methods applied their methods to model the same set of cryo-EM
maps and deposited the resultant structures onto a public-accessible server [34]. We participated in
the challenge by applying MDFF to obtain atomic models for seven density maps provided by the
challenge, covering a wide range of system sizes (single proteins to large complexes) and resolutions
(2.5–8 A˚). The results of our participation are described in Chapter 4 and were published in [7].
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1.3 The ribosomal protection protein Tet(O)
The ribosome is the target of many antibiotic drugs [1]. However, the continuously growing bacterial
resistance to antibiotics has rendered many existing antibiotics ineffective, creating a constant need
for new types of antibiotics. To design new types of antibiotics, it is indispensable to understand the
physical mechanism of bacterial resistance to antibiotics.
Tetracycline (Tc), a previously widely-used antibiotic [35], is nowadays of limited use because
of the emergence of bacterial resistance. One resistance mechanism employed by bacteria involves
Figure 1.5: MDFF model of a Tet(O)-bound ribosome inside the
EM density map. The Tet(O) protein is colored in dark blue.
binding of a so-called ribosomal protec-
tion protein, Tet(O), to the bacterial ri-
bosome which actively removes Tc from
the bacterial ribosome [36, 37]. However,
due to the lack of high resolution struc-
tural data of Tet(O)-bound ribosome, the
mechanism behind Tet(O)-mediated resis-
tance remains elusive. In collaboration with
Joachim Frank (Columbia U.), MDFF was
applied to a cryo-EM map of Tet(O)-bound
ribosome at 9.6 A˚ to obtain the first atomic
model of the system (Fig. 1.5). The model
of the ribosome-Tet(O) complex revealed
three critical loops of Tet(O) which promote
the unbinding of Tc from the ribosome in
various ways. Findings from our cryo-EM analyses were confirmed by mutation experiments. The
results are described in Chapter 5 and were published in [8].
1.4 The ribosome-bound chaperone trigger factor
During protein synthesis, nascent protein chains exit the ribosome through the ribosomal exit tunnel
while still being elongated inside the ribosome (Fig. 1.1). Various types of ligands bind to the ribosome
to interact with the exiting nascent chain for different functional purposes. For example, in case of
a membrane protein nascent chain, the ribosome docks to a SecY system on a cellular membrane
to co-translationally insert the nascent protein into the membrane [21]; in case of cytosolic nascent
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proteins, a protein called trigger factor (TF) binds to the ribosomal exit site (Fig. 1.1) to protect the
nascent chain from pre-mature folding and aggregation [38, 39] by retarding folding [40, 41] or even by
unfolding folded domains of the nascent chain during translation [41]. Deletion of the TF and another
chaperone, DnaK, from living cells results in a decreasing yield of de novo protein folding and can be
lethal [42, 43]. However, the actual chaperone activities of the TF remain elusive.
Figure 1.6: The trigger factor is poorly resolved by cryo-EM beyond the ribosome binding domain. Densities of the
other two domains are only visible when the map is low-pass filtered to 16.5 A˚ and 35 A˚, respectively, suggesting a
highly mobile TF on the ribosome.
To resolve the molecular mechanism underlying the functions of the TF, high resolution structural
data of TF binding to a translating ribosome are needed. Our collaborator Roland Beckmann (U.
Munich) resolved cryo-EM structures of the ribosome-trigger factor-nascent chain complex. However
in the cryo-EM data, two out of three TF domains are poorly resolved, suggesting a highly dynamic
TF on the ribosomal surface (Fig. 1.6). We first applied MDFF to obtain an atomic model for regions
that are well resolved in the EM map, and then performed microseconds-long simulations to sample
the conformations of the poorly resolved TF domains. Our simulations reveal that the dynamics of
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TF is dependent on the length of the nascent peptide; this dependence originates from the interactions
between the TF and the nascent chain and is physiologically important for the chaperone function of
the trigger factor. The results are described in Chapter 6 and were submitted for publication [9].
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Chapter 2
Symmetry-restrained flexible fitting
Reproduced in part with permission from Kwok-Yan Chan, James Gumbart, Ryan McGreevy, Jean M.
Watermeyer, B. Trevor Sewell, and Klaus Schulten. Symmetry-restrained flexible fitting for symmetric
EM maps. Structure, 19:1211-1218. Copyright 2011 Elsevier.
2.1 Introduction
Structural information is essential for understanding function and mechanism of biological systems.
The state of the art in macromolecular structure determination permits the structural characterization
of such molecules at multiple resolutions. X-ray crystallography, the predominant high-resolution
technique, provides structural data at the atomic scale, but often requires non-physiological conditions
to achieve crystallization. Furthermore, certain macromolecular assemblies, such as the ribosome or
those with quaternary helical structure, are difficult to crystallize or cannot be crystallized at all.
On the other hand, cryo-electron microscopy (cryo-EM) can capture images of molecules in functional
states and for large systems, but typically at lower resolution (3.3-30 A˚) than X-ray crystallography [44,
45, 13, 46, 21].
The resolution gap between X-ray crystallography and cryo-EM can be bridged by using hybrid
computational methods to combine the two sources of experimental data. An early approach is the so-
called rigid-body docking, which treats X-ray structures as rigid and searches for an orientation that
best fits the cryo-EM map [47]. Even though this approach provides an excellent first approximation
to the fit, it lacks the flexibility needed to deal with molecules that exhibit relative motions between
individual parts in different functional states. Hence, a new class of flexible fitting methods has been
developed, in which the X-ray structures or homology models have more degrees of freedom to deform
and fit the cryo-EM map. An early attempt at flexible fitting involved dividing the molecule into
different parts and then docking each rigid part into the density independently [48]. Another early
approach utilized real-space refinement, a technique developed for X-ray crystallography, to fit the
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structure into the map [49, 50]. Other means of flexible fitting include (1) matching reduced-complexity
representations of the structure and the density map to deform the structure [51], (2) altering the
structure along the low frequency normal modes to increase the correspondence to the density map [52,
26, 53], (3) fitting comparative models based on different sequence-structure alignments and loop
conformations of different components [54], (4) using a deformable elastic network and restraints from
EM data to morph the structure [55], and (5) refining segments of protein homology models locally
within EM data before global refinement of the whole protein [56]. A recently developed flexible fitting
method, molecular dynamics flexible fitting (MDFF), employs molecular dynamics (MD) simulations
to perform flexible fitting by incorporating the EM data as an external potential in conventional MD
simulations [3].
In any of these flexible fitting methods, the quality of the final fitted structure is strongly related
to the resolution of the map and the quality of the starting model. A lower resolution map does not
represent as much information as a higher resolution map and, hence, allows more degrees of freedom
to participate a fitting procedure. Moreover, the accuracy of a structure fitted to a low-resolution map
maybe limited by structural variability in the dataset, which reduces the useful structural information
one can extract. One way to improve the quality and accuracy of structures fitted into EM data,
especially in case of low-resolution maps, is to incorporate additional knowledge about the structure in
the fitting procedure. For example, many biological systems are symmetric in nature, such as poliovirus
exhibiting icosahedral symmetry [57] and potassium channels exhibiting four-fold symmetry [58]. Point
group symmetry and helical symmetry also occur frequently in biological systems. This symmetry is
functionally important, e.g., for increasing structural stability [59, 60, 61], for cooperative or allosteric
functions [62, 63], and for folding [64, 65]. Indeed, symmetry information of biomolecules has already
been incorporated in structure prediction tools like Rosetta [66]. Protocols to impose restraints
enforcing symmetry during MD simulations have also been developed and have been used in the
refinement of homology models of potassium channels [67]. Symmetry information can be extracted
even from low-resolution EM data, and symmetric averaging is commonly used to improve the signal-
to-noise ratio of a dataset. By integrating the same symmetry information into flexible fitting protocols
to ensure a symmetric fitted structure, one can effectively reduce the number of available degrees of
freedom in the fitting problem and, hence, improve the quality of fitted models. A similar idea has been
employed in normal mode-based fitting of virus capsids in which only modes obeying the icosahedral
symmetry were retained [26].
We present here a method to incorporate the symmetry information extracted from EM data into
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MDFF. The symmetry relationship among subunits is converted into harmonic restraints, which are
then applied to maintain the structure’s symmetry during MDFF simulations. The benefit derived
from symmetry restraints is most apparent for low-resolution EM data as high-resolution data already
contains sufficient information to maintain the symmetry during MDFF simulations. We applied the
symmetry restraints to three different systems for which experimental EM data are available, namely
the GroEL-GroES complex, a nitrilase from Rhodococcus rhodochrous J1, and a chaperonin from the
archaeon Methanococcus maripaludis (Mm-cpn). These test cases represent data having three different
symmetries and a range of resolutions, and serve to illustrate the benefits of applying symmetry
restraints during MDFF.
2.2 Results
Symmetry restraints
The MDFF method is based on molecular dynamics simulation [3] and has already been used success-
fully in numerous applications [17]. Starting from an initial atomic structure, usually an X-ray crystal
structure, an MD simulation is performed. In this simulation, two additional energy terms are added
to the standard MD force field potential UMD. The first term, UEM, is derived from the EM density,
and is used to apply forces proportional to the gradient of the density map to the atoms. This drives
the model towards high density regions of the map and, hence, effectively guides the structure to the
conformational state represented by the EM density. The stereochemical correctness of the structure
is ensured by the standard MD force field. In addition, a second term, USS, which preserves the
secondary structure of the system by imposing harmonic restraints on specific dihedrals, is included
to avoid overfitting, i.e., to avoid unphysical distortions caused by the UEM term when a structure
is too closely fitted to the EM map. A practical guide for carrying out MDFF simulations has been
published previously [4]. Since MDFF is based on MD simulations, thermal fluctuations in the fitting
simulations can lead to multiple solutions that fit a map. Hence, different symmetric units can arrive
at different conformations even for a symmetric map.
The symmetry information of the cryo-EM data can be incorporated into an MDFF simulation
through an additional potential to maintain a symmetric structure during the simulations. Since it is
a common practice to symmetrize EM data for symmetric molecules during the 3D EM reconstruction
process [27, 28, 29], the type of symmetry and its parameters, e.g., helical rise and twist for a helically
symmetric system, can be obtained from this process.
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A new potential energy term USR is built according to the symmetry information as follows. Let
Ri(t) be the set of coordinates for atoms of the i-th symmetric unit at time t during the simulation,
where Ri(t) for different units are related by a predefined symmetry. The symmetry information is
used to generate, for each unit i, a transformation
↔
Ui, which superimposes the coordinates Ri of unit i
onto the first unit. Averaging over these superimposed symmetric units, the coordinates of an average
structure, Ravg(t) =<
↔
Ui Ri(t) >, can be calculated. Using the inverse transformation
←→
U−1i for each
unit, the average structure is transformed backwards from the first unit to the respective i-th unit;
the resulting set of backward-transformed coordinates, R′i(t) =
←→
U−1i Ravg(t) =
←→
U−1i <
↔
Ui Ri(t) > are
now perfectly symmetric. The deviation between R′i(t) and Ri(t) is measured by their root mean
square distance (RMSDi), defined by
RMSDi(t) =
√
< |Ri(t)−R′i(t)|2 > =
√
< |Ri(t)−
←→
U−1i <
↔
Ui Ri(t) > |2 > (2.1)
where the average is taken over a chosen subset of atoms in the i-th unit. A high RMSDi indicates
a large deviation from the ideal symmetric structure.
To minimize RMSDi between each unit and its corresponding unit in the average structure, the
potential energy term USR mentioned above is added, given by
USR =
1
2
k(t)
∑
i
[RMSDi(t)]
2 (2.2)
where the sum is taken over all units. This potential term defines forces applied to the chosen
subset of atoms in order to minimize RMSDi(t) during the simulations and, hence, guide the system
towards a symmetric structure. The factor k(t) with unit energy/length2 controls the strength of
the applied forces and can either be set to a constant or be linearly increased over time. A k(t),
linearly increasing up to a finite value, is recommended so that during the early steps of fitting, the
structure has sufficient flexibility to explore the conformational space represented by the EM data
before converging to a symmetric structure as the symmetry restraint forces increase. The subset
of atoms within a unit on which the RMSD calculation is based and to which forces are applied is
typically chosen to be the Cα atoms for proteins instead of all atoms, so that the structure will not
be over-restrained.
We applied MDFF with and without symmetry restraints to three exemplary applications, namely
GroEL-GroES complexes, nitrilase from R. rhodochrous J1 and Mm-cpn (see Figure 2.1). For all three
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Figure 2.1: Symmetries of the example applications, showing side and end-on views of each. (A, B) Seven-fold symmetric
GroEL-GroES complex (C7 symmetry). (C, D) Helically symmetric nitrilase of R. rhodochrous J1 (D1S4.9 symmetry).
(E, F) Sixteen-fold symmetric units of Mm-cpn (D8 symmetry).
cases, we calculated along the fitting trajectory the average RMSD between symmetric units, defined
by < RMSDi(t) >=
1
N
∑
iRMSDi(t), where N is the number of symmetric units. As shown in
Figures 2.2A,B and D, in all three examples, the average RMSD between symmetric units for fitting
with symmetry restraints applied is lower than that for fitting without symmetry restraints. The
lower RMSD demonstrates that the symmetry restraints work as intended.
Example 1: GroEL-GroES complexes
The first example involves MDFF for the GroEL-GroES complex. The Escherichia coli chaperonin
GroEL, together with the lid-like co-chaperonin GroES, form a molecular machine that assists the
folding of many proteins with the help of ATP binding and hydrolysis. Upon ATP hydrolysis, the
GroEL-GroES complex undergoes conformational changes necessary to carry out its function of me-
diating protein folding [68]. Crystal structures of an analogue of the ATP-bound state [69] and a
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Figure 2.2: Average Cα RMSD values along the fitting trajectories of (A) GroEL-GroES complex, (B) Nitrilase of
R. rhodochrous J1, (C) Mm-cpn closed state (4.3 A˚) and (D) Mm-cpn open state (8 A˚). The average RMSD value is
defined through < RMSDi(t) >=
1
N
∑
iRMSDi(t) where N is the number of symmetric units. Red and black curves
in (A)-(D) correspond to fitting with and without symmetry restraints, respectively. In (D), solid lines represent fitting
using a homology model, while dashed lines represent fitting using a crystal structure with (blue) and without (green)
symmetry restraints.
post-hydrolysis ADP-bound state [70] are available, but appear to be identical, failing to resolve the
structural and functional differences between the two states. In contrast, both states have been cap-
tured in cryo-EM maps that have successfully resolved potentially important structural differences
between them [71], suggesting that crystal packing may have favored non-physiological conformations
in the published crystal structures.
GroEL comprises two back-to-back seven-membered rings and, together with the co-chaperonin
GroES, forms a complex with a seven-fold rotational symmetry, as illustrated in Figures 2.1A and
B. We applied MDFF to fit an ADP-bound structure (PDB code 2C7D), which was modelled from
cryo-EM data [71], into the EM map of an ATP-bound complex, both with and without symmetry
restraints. The target cryo-EM data used here is an intermediate resolution (7.7 A˚) map of the
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complex in an ATP-bound state [71], obtained from the EM data bank (EMD-1180).
Figure 2.3: Comparison of symmetry-restrained fitted structures (blue) to known structures (red) of the corresponding
proteins. (A) GroES (RMSD 1.73 A˚). (B) GroEL cis-ring (RMSD 1.15 A˚). (C) GroEL trans-ring (RMSD 2.51 A˚). (D)
β-sheet region (residues 37-51 of the GroEL trans-ring subunit) of the symmetry-restrained fitted structure (blue) and
the published structure (red) in the ATP-bound state inside the EM map. (E,F) Apical domain of the Mm-cpn lidless
open state. Both a homology model (E, RMSD 5.31 A˚) and a crystal structure (F, RMSD 2.34 A˚) of a closed state
were used for fitting.
To validate the structure fitted with symmetry restraints, a comparison was made to an available
structure (PDB code 2C7C) modelled from the same map used here. The RMSD of the full GroEL-
GroES complex, compared to the published structure, decreases from 2.21 A˚ to 1.97 A˚ (fitted without
symmetry restraints) and 1.93 A˚ (fitted with symmetry restraints) during the fitting. From Figure 2.3
it can be seen that GroES (RMSD 1.73 A˚, Figure 2.3A), the GroEL cis-ring (RMSD 1.15 A˚, Fig-
ure 2.3B) and the GroEL trans-ring (RMSD 2.51 A˚, Figure 2.3C) of the fitted structure are all very
similar to the EM-modelled structure. Furthermore, the chief observable structural difference between
the published ATP- and ADP-bound structures modelled from EM data, namely a shorter inter-strand
distance between β-sheets in adjacent subunits of the trans-ring in the ATP-bound state [71], is also
captured in our fitted structure. However, the separation between the β-sheets observed in our fitted
structure of the ATP-bound state is wider. The wider inter-strand distance agrees better with the
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map than the published structure, as shown in Figure 2.3D. Such a difference can be attributed to
the fact that the trans-ring of the published structure was obtained by rigid-body docking of three
domains to the map, which failed to capture intra-domain motions.
After fitting, free equilibration of both the symmetry-restrained and unrestrained fitted structures
was carried out. From the 10-ns trajectory of both simulations, the backbone RMSD of the entire
complex with respect to the first frame (i.e., the final fitted structure) was calculated. In Figure 2.4A,
it can be seen that the simulation starting from a structure fitted with symmetry restraints equili-
brates faster and has a lower backbone RMSD than the one starting from a structure fitted without
symmetry restraints. The shorter time needed to equilibrate and the lower RMSD value (Figure 2.4A)
demonstrate that a more stable structure has been obtained using the symmetry restraints during the
fitting. The stability of the fitted structure is particularly important if the system is to be subjected
to further MD simulations.
Example 2: Nitrilase
The second example involves a nitrilase from R. rhodochrous J1, a member of the superfamily of
nitrilases, amidases, acyl transferase and N -carbamoyl-D-amino acid amidohydrolases. Nitrilases
convert nitriles to the corresponding carboxylic acids and ammonia; an oligomerization of individual
protein dimers into spiral homo-oligomers is important for their enzymatic function [72, 73]. In
particular, the nitrilase from R. rhodochrous J1 was found to be inactive in its dimer form, but active
in its helical-fiber form [74]. Negative stain and cryo-EM have been used to resolve the 3D structure
of these helical fibers for native nitrilases as well as mutants [73, 75], in order to understand the
relationship between function and spiral quaternary structure formation in the nitrilase family.
We applied MDFF to fit a two-turn-helix model of R. rhodochrous J1 nitrilase, consisting of nine
dimers, into a low resolution (18 A˚) negative stain EM map of a long helix fiber (EMD-1313) [74].
The atomic structure of the dimer of R. rhodochrous J1 nitrilase used is a homology model based
on crystal structures of four nitrilase homologues (PDB codes: 2PLQ, 3HKX, 1J31, 2VHH (Thuku,
personal communication)). The helical symmetry of the fiber is parametrized by the helical twist
(azimuthal rotation around the helical axis) and the helical rise (rise along the helical axis) between
adjacent dimers. The helical twist and rise of the published map were -73.65◦ and 15.8 A˚, respectively,
with a D1S4.9 symmetry [74].
Because only two helical turns were used for the atomic model, while the map covered six turns,
the first and the last dimers at the edge of the model were attracted by the adjacent, empty density.
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Indeed, in the fitting without symmetry restraints, certain parts of the first and last dimers were pulled
into this density, leading to structural distortions, as illustrated in the blue structure in Figure 2.4B.
However, in the fitting with symmetry restraints, both the first and last dimers maintained their
dimer form inside their corresponding density envelope (red structure in Figure 2.4B). The difference
in dimer behavior shows that the symmetry restraints prevent edge-distortion effects, which arise
whenever one is fitting only a part of the full system into the map. Segmenting the maps and removing
the density where no dimers are placed may be a possible way to avoid edge-distortion effects, but
map segmentation is prone to human error and proper cutting of boundaries is not always achieved.
Although this problem can be addressed more directly by doing a fitting for the full system, there
are occasions in which fitting of only a portion is desirable. In the J1 nitrilase system, a two-turn
helix model is sufficient for determining how inter-dimer interactions give rise to the stability of a
spiral structure; fitting more dimers into the long helical EM data would be computationally costly
and unnecessary. This strategy may be appropriate to other symmetries such as virus capsids, which
have icosahedral symmetry and for which full-system fitting would be computationally prohibitive.
Figure 2.4: (A) Backbone RMSD of the GroEL-GroES complex with respect to the fitted structure during free equilibra-
tion after fitting. Red and black curves correspond to starting structures which were fitted with and without symmetry
restraints, respectively. (B) Two-turn-helix fitted structure of R. rhodochrous J1 nitrilase. Red and blue structures
were fitted with and without symmetry restraints, respectively. The first and last dimers of the structure fitted without
symmetry restraints are pulled towards the density of adjacent dimers and are distorted as a consequence, while these
dimers remain intact in case of structures fitted with symmetry restraints.
Example 3: Mm-cpn
The last example features Mm-cpn, an archaeal group II chaperonin, which mediates protein fold-
ing. Mm-cpn is composed of two back-to-back eight-membered rings, but unlike the GroEL-GroES
complexes, the rings are related by a two-fold axis giving rise to 16 symmetric units in the system.
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To carry out its function, a built-in lid closes upon ATP hydrolysis, the latter inducing structural
rearrangements which have been illuminated by cryo-EM [76].
We applied MDFF to model the structures represented by two distinct maps, one at medium
resolution (8 A˚) of a lidless Mm-cpn in the open state (EMD-5140) and one at high resolution (4.3 A˚)
of a full Mm-cpn in the closed state (EMD-5137) [76]. For the medium-resolution lidless open-state
map, MDFF was used to fit a lidless closed-state homology model, built from the sequence of a lidless
Mm-cpn and a full closed-state structure (PDB code 3LOS), into the EM data. For the high-resolution
full closed-state map, MDFF was used to refine and improve the full closed-state structure (PDB code
3LOS).
The Mm-cpn example showcases the usefulness of symmetry restraints in dealing with lower (8 A˚)
resolution EM data. As shown in Figure 2.2C, fitting with and without symmetry restraints gives a
similar average RMSD for Cα atoms among the symmetric units in the 4.3-A˚-resolution map. However,
for the lower resolution (8 A˚) open-state map, the symmetry restraints are required to preserve the
symmetry of the system. For high-resolution data, the conformational space allowed by the map is
more confined than for low-resolution maps and, hence, during the fitting to them, all units converge
to the same conformation in the absence of symmetry restraints. In contrast, there are significantly
more possible conformations for a symmetric unit fitted to a lower resolution map, causing different
units’ conformations to diverge during the fitting and, thus, giving a non-symmetric structure when
fitted without the symmetry restraints.
We compared our symmetry-restrained fitted model of the Mm-cpn lidless open state to a recently
released crystal structure (PDB code 3KFK [77]), finding that the apical domain exhibits noticeable
structural differences between them (RMSD 5.32 A˚, see Figure 2.3E). Such differences may be due
to the inaccuracy of the initial homology model of a lidless closed-state. To eliminate this source of
inaccuracy, we performed fittings for the lidless open state map using a different starting structure,
a crystal structure of the lidless closed state (PDB code 3KFE [77]). As shown in Figure 2.3F, a
structure in better agreement with the open-state crystal structure (RMSD 2.34 A˚) was obtained. The
improvement in the fitted model demonstrates the importance of using a good starting structure for
fitting. Furthermore, the structure obtained with symmetry-restrained fitting is in better agreement
with the crystal structure (RMSD 2.34 A˚) compared to fitting without symmetry restraints (RMSD
2.83 A˚), showing again that symmetry-restrained fitting can improve the quality of fitted structures.
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2.3 Discussion
We have developed a new type of restraint that maintains the symmetry of a system during MDFF
simulations by utilizing symmetry information extracted from cryo-EM data. Application to Mm-cpn
demonstrates that when employing MDFF without symmetry restraints, the symmetry is distorted
more heavily during fitting of lower resolution data, namely 8 A˚ vs. 4.3 A˚ data, because for each
symmetric unit, more structural variability is allowed by a lower resolution map. Hence, symmetry
restraints should be employed when one is modeling low to medium resolution symmetric EM data
by MDFF. However, even when using symmetry restraints, the quality of the starting structure plays
a significant role in the fitting, exemplified by Mm-cpn (see Figures 2.3E,F).
As shown in the free equilibration simulations of the GroEL-GroES complex, a more stable struc-
ture, i.e., one more suitable for further MD simulations, can be obtained with the application of
symmetry restraints during fitting. The finding is in agreement with previous simulations of homol-
ogy models of potassium channels refined by symmetry-restrained MD simulations [67], which is an
example of an alternative use of symmetry restraints in MD simulations other than MDFF. Another
benefit of using symmetry restraints is the prevention of edge-distortion effects, which arise when one
is fitting only a portion of the system into the map, as illustrated above for R. rhodochrous J1. The
benefits of using symmetry restraints demonstrated for the three example systems are also applicable
to biological complexes possessing other types of symmetry, such as the icosahedral symmetry of virus
capsids. The generalization is straightforward as the transformations arising in Equations 2.1 and 2.2
can be defined also for other symmetry types.
In symmetry-restrained fitting simulations, thermal noise tends to drive the system away from
symmetry whereas the restraints counteract this tendency, limiting conformations to those that remain
close to the symmetric structure. At physiological temperature, small deviations from symmetry arise
naturally, especially at the side-chain level. Hence, in general it is not recommended to apply symmetry
restraints to all atoms, which can produce a structure that adheres to the symmetry perfectly, but
may also be non-physiological due to overly restraining it, akin to the over-fitting problem for cryo-EM
maps [3]. Instead, applying symmetry restraints to Cα atoms only can avoid over-restraining while
still maintaining the secondary and tertiary structural symmetry of the system. The balance between
thermal fluctuations and symmetry is controlled by the force constant k(t), which is recommended to
be increased linearly over the fitting simulation so that the system can explore more conformational
space as allowed by the map before converging to a symmetric structure. A maximum force constant
20
of 10 (kcal/mol)/A˚2 was chosen in our examples, from which deviations of atomic positions from the
average will be ∆x ∼ √kBT/k = 0.25 A˚ only, thus maintaining the symmetry well. Indeed, in our
examples, a linearly increasing k(t), reaching 10 (kcal/mol)/A˚2, proved to be sufficient to guide the
system to a nearly symmetric structure (see convergence of average RMSD in Figures 2.2) within a
simulation time of 5 ns.
There are alternatives to symmetry restraints that can give a symmetric fitted structure. For exam-
ple, one may fit only one symmetric unit into a segmented map and then generate the whole structure
using the symmetry transformations. Although this will result in a perfectly symmetric structure, fit-
ting in the presence of other symmetric units should be preferred as this will produce a more reliable
structure at the interfaces between different units. Indeed, clashes may arise when one attempts to
generate the whole structure from only a single fitted subunit, while in symmetry-restrained fitting the
MD force field prevents such clashes. One may also average the individual structures of all symmetric
units at the end of the fitting protocol, performing a so-called “instantaneous symmetrization”. This
will give a perfectly symmetric structure, but the average of units in different conformations is not
likely to be physically realistic or biological relevant. In contrast, the symmetry restraints will bias all
units towards the same conformation during the fitting. The advantage of using symmetry restraints
during the simulations over “instantaneous symmetrization” has also been demonstrated previously
using symmetry-restrained MD simulations of tetrameric potassium channels [67].
Symmetry is common and often functionally important for biological systems, but there are cases
where symmetry breaking arises during function. An example occurs during viral entry into the
cell, which starts with binding of the icosahedrally symmetric virus capsid to receptors on the cell
membrane, inducing then a conformational transition of the capsid for injection of the genome into the
cell [78]; clearly, upon binding to the receptor, the symmetry of the virus capsid is broken. Naturally,
symmetry-restrained fitting does not capture highly asymmetric regions in a system given that the
map itself is symmetric, but subsequent MD simulations without any restraints applied permit the
development of asymmetry. Root-mean-square fluctuations (RMSF) of atoms during simulations,
which measure the deviation of atoms from their average positions, can reveal regions that are more
flexible and, hence, more likely to become asymmetric.
It is common for multiple symmetries to co-exist in a biological system; for example, the family
of nitrilases exhibits a two-fold symmetry in addition to the helical symmetry. Therefore, extending
symmetry restraints to handle multiple symmetries in a single simulation is desirable and, indeed, is
already developed. A tutorial on applying symmetry restraints during an MDFF simulation has been
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developed and is available at http://www.ks.uiuc.edu/Training/Tutorials/.
2.4 Methods
All systems utilized in the example applications were first rigid-body docked into the EM map using
Colores from the Situs package [51], and then solvated in a box of TIP3P [32] water molecules, using
10 A˚ padding in all directions. Counter ions Na+ and Cl− were added to neutralize the systems. The
simulations were performed with a development version of NAMD 2.8 [11] using the CHARMM27 force
field with CMAP corrections [79, 80]. Only water and ions were allowed to equilibrate for the first 500
ps by constraining the protein with harmonic restraints, followed by equilibration of side chains as the
protein backbone remained constrained. Next, MDFF simulations were performed for 5 ns in each
case, coupling only non-hydrogen atoms of the protein to the UEM potential with a grid scaling of 0.3,
which controls the balance between UMD and UEM [3]. In addition to secondary structure restraints,
restraints were used to maintain the correct chirality at all chiral centers and to keep peptide bonds
in the trans-configuration. Finally 3000 steps of energy minimization, in the presence of UEM with
grid scaling of 10, were performed to increase the stability of the resulting structure by removing the
thermal deviations in the systems. For simulations using symmetry restraints, the force constant k
was increased linearly from 0 to 10 (kcal/mol)/A˚2 during the 5-ns MDFF simulations and forces were
applied only to Cα atoms. All simulations were carried out in the NVT ensemble, using the following
parameters: constant temperature at 300 K was maintained using Langevin dynamics with a damping
constant of 5 ps−1; long-range electrostatic forces were computed using the particle-mesh Ewald
summation method with a grid spacing of 1 A˚; the RESPA multiple-time-stepping algorithm [81, 82]
was employed with an integration time step of 1 fs, short-range forces evaluated every 2 time steps,
and long-range electrostatics evaluated every 4 time steps.
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Chapter 3
MDFF with implicit solvent model
Reproduced in part with permission from David E. Tanner, Kwok-Yan Chan, James Phillips, and
Klaus Schulten. Parallel generalized Born implicit solvent calculations with NAMD. J. Chem. Theor.
Comp., 7:3635-3642. Copyright 2011 American Chemical Society.
3.1 Introduction
Molecular dynamics (MD) is a computational method [83] employed for studying the dynamics of
nanoscale biological systems on nanosecond to microsecond timescales [84]. Using MD, researchers
can utilize experimental data from crystallography and cryo-electron microscopy (cryo-EM) to explore
the functional dynamics of biological systems [4].
Because biological processes take place in the aqueous environment of the cell, a critical component
of any biological MD simulation is the solvent model employed [30, 31]. An accurate solvent model
must reproduce water’s effect on solutes such as the free energy of solvation, dielectric screening of
solute electrostatic interactions, hydrogen bonding and van der Waals interactions with solute. For
typical biological MD simulations, solute is comprised of proteins, nucleic acids, lipids or other small
molecules.
Two main categories of solvent models are explicit and implicit solvents. Explicit solvents, such as
SPC [85] and TIP3P [32], represent water molecules explicitly as a collection of charged interacting
atoms and calculate a simple potential function, such as Coulomb electrostatics, between solvent and
solute atoms. Implicit solvent models, instead, ignore atomic details of solvent and represent the
presence of water indirectly through complex interatomic potentials between solute atoms only [86,
87, 88]. There are advantages and disadvantages of each solvent model.
Simulation of explicit water is both accurate and natural for MD, but often computationally too
demanding, not only since the inclusion of explicit water atoms increases a simulation’s computational
cost through the higher atom count, but also because water slows down association and disassociation
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processes due to the relatively long relaxation times of interstitial water [89]. The viscous drag of
explicit water also retards large conformation changes of macromolecules [90].
An alternative representation of water is furnished by implicit solvent descriptions which eliminate
the need for explicit solvent molecules. Implicit water remains always equilibrated to the solute.
The absence of explicit water molecules also eliminates the viscosity imposed on simulated solutes,
allowing faster equilibration of solute conformations and better conformational sampling. Examples
of popular implicit solvent models are Poisson-Boltzmann electrostatics [91, 92], screened Coulomb
potential [87, 93], analytical continuum electrostatics [94] and generalized Born implicit solvent [95].
The generalized Born implicit solvent (GBIS) model, used by MD programs CHARMM [96, 97],
Gromacs [98, 99], Amber [100] and NAMD [11, 101], furnishes a fast approximation for calculating
the electrostatic interaction between atoms in a dielectric environment described by the Poisson-
Boltzmann equation. The GBIS electrostatics calculation determines first the Born radius of each
atom, which quantifies an atom’s exposure to solvent, and, therefore, its dielectric screening from
other atoms. The solvent exposure represented by Born radii can be calculated with varying speeds
and accuracies [102] either by integration over the molecule’s interior volume [103, 104] or by pairwise
overlap of atomic surface areas [95]. GBIS calculations then determine the electrostatic interaction
between atoms based on their separation and Born radii.
GBIS has benefited MD simulations of small molecules [105]. For the case of large systems, whose
large conformational motions [106] may benefit most from an implicit solvent description, but which
must be simulated on large parallel computers [107], requiring efficient parallel GBIS algorithms.
NAMD addresses the computational challenges of parallel GBIS calculations and efficiently simulates
large systems. Details of NAMD’s GBIS model and the implementation are described in [6].
The molecular dynamics flexible fitting (MDFF) method [3, 4, 10] is a MD simulation method that
matches crystallographic structures to an electron microscopy (EM) map; crystallographic structures
often correspond to non-physiological states of biopolymers while EM maps correspond often to func-
tional intermediates of biopolymers. The MDFF method adds to a conventional MD simulation an EM
map-derived potential, thereby driving a crystallographic structure towards the conformational state
represented by an EM map. Shortcomings of MDFF are largely due to the use of in vacuo simulations;
such use was necessary hitherto as simulations in explicit solvent proved too cumbersome. Implicit
solvent MDFF simulations promise a significant improvement of the MDFF method. To demonstrate
the benefit of using NAMD’s GBIS model in MDFF, we simulate the ∼250,000-atom ribosome using
MDFF with different solvent models and compare behavior of different solvent models in these MDFF
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simulations.
3.2 Results
The ribosome is the cellular machine that translates genetic information on mRNA into protein chains.
During translation, tRNAs, with their anti-codon loops to be matched to the genetic code on mRNA,
carry amino acids to the ribosome. The synthesized protein chain is elongated by one amino acid each
time a cognate tRNA (with its anti-codon loop complementary to the next mRNA codon) brings an
amino acid to the ribosome; a peptide bond is formed between the new amino acid and the existing
protein chain. The ribosome complex fluctuates between two conformational states, namely the so-
called classical and ratcheted state [108], during the elongation process. The transition from classical
to ratcheted state involves multiple, large conformational changes, including an inter-subunit rotation
between its 50S and 30S subunits [108] and the closing of its L1 stalk in the 50S subunit [109] (see
Figure 3.1). The large conformational changes during the transition from classical to ratcheted state
are essential for translation [110] as suggested by previous cryo-EM data [45]. MDFF-derived models
of the classical and ratcheted state ribosome provide atomic-level details crucial to understanding
protein elongation in the ribosome.
A high-resolution classical state ribosome structure was fitted into a low-resolution ratcheted state
EM map in an in vacuo MDFF simulation as well as MDFF simulations employing explicit and
implicit solvent. The rate of convergence and relative accuracy of solvent models in the three MDFF
simulations are characterized by the root-mean-square deviation between models, defined as follow:
RMSDsol,ref(t) =
√√√√ N∑
i
[~ri,sol(t)− ~ri,ref ]2 /N , (3.1)
where ~ri,sol(t) denotes the atomic coordinates at time t of the simulation corresponding to one of the
three solvent models (exp, imp or vac) and ~ri,ref denotes the atomic coordinates for the last time
step (tf = 3 ns) of the simulation using the reference solvent model (exp, imp or vac) as specified
below. Unless otherwise specified, the summation is over the N = 146, 000 heavy atoms excluding the
mRNA, L10 and L12 protein segments which are too flexible to be resolved by the cryo-EM method.
Figure 3.1 plots RMSDexp,exp(t), RMSDimp,exp(t) and RMSDvac,exp(t) that compare each MDFF
simulation against the final structure reached in the explicit solvent case. We note that using the
initial rather than final structure as the reference could yield a slightly different characterization of
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Figure 3.1: Molecular dynamics flexible fitting (MDFF) of ribosome with NAMD’s GBIS method. While matching the
250,000-atom classical ribosome structure into the EM map of a ratcheted ribosome, the 30S subunit (green) rotates
relative to the 50S subunit (blue) and the L1 stalk moves 30 A˚ from its classical (tan) to its ratcheted (magenta)
position. Highlighted (red) are regions where the implicit solvent structure agrees with the explicit solvent structure
much more closely than does the in vacuo structure. The root-mean-squared deviation (RMSDsol,exp(t)) of the ribosome,
defined in eq. 3.1, with the final fitted explicit solvent structure as reference, is plotted over time for explicit solvent
(RMSDexp,exp(t) in black), implicit solvent (RMSDimp,exp(t) in purple) and in vacuo (RMSDvac,exp(t) in red) MDFF.
While the explicit solvent MDFF calculation requires 2-3 ns to converge to its final structure, both implicit solvent
and vacuum MDFF calculation require only 0.5 ns to converge. As seen by the lower RMSD values for t > 0.5 ns, the
structure derived from the implicit solvent fitting agrees more closely with the final explicit solvent structure than does
the in vacuo structure. While this plot illustrates only the overall improvement of the implicit solvent structure over the
in vacuo structure, the text discusses key examples of ribosomal proteins (L27, S13 and L12) whose structural quality
is significantly improved by the use of implicit solvent.
convergence [111], e.g., a slightly different convergence time. As manifested by RMSDimp,exp(t) and
RMSDvac,exp(t), the implicit solvent and vacuum MDFF calculations converge to their respective final
structures in 0.5 ns compared to 2-3 ns for the explicit solvent case, i.e., for RMSDexp,exp(t).
The final structures obtained from the MDFF simulations are compared in Table 3.1 through the
RMSDsol,ref(t) values for t = 3 ns. The ribosome structure from GBIS MDFF closely agrees with
the one from explicit solvent MDFF as indicated by the value RMSDimp,exp(3 ns) = 1.5 A˚; the in
vacuo MDFF ribosome structure, however, compares less favorably with the explicit solvent MDFF
structure as suggested by the larger value RMSDvac,exp(3 ns) = 1.9 A˚. While the 0.4 A˚ improvement
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in RMSD of the GBIS MDFF, over in vacuo MDFF, structure implies an overall enhanced quality,
certain regions of the ribosome are particularly improved.
Reference
exp imp vac
S
ol
ve
n
t exp 0 1.5 1.9
imp 1.5 0 2.1
vac 1.9 2.1 0
Table 3.1: Root-mean-square deviation (RMSDsol,ref(3 ns) in A˚) between the three final ribosome structures
matched using explicit solvent, GBIS, and in vacuo MDFF. The GBIS and explicit solvent MDFF structures
closely agree as seen by RMSDimp,exp(3 ns) = 1.5 A˚, while the in vacuo MDFF structure deviates from the
explicit solvent MDFF structure by RMSDvac,exp(3 ns) = 1.9 A˚. See also Figure 3.1.
The regions with the highest structural improvement (highlighted red in Figure 3.1) belong to
segments at the exterior of the ribosome and to segments not resolved by and, therefore, not coupled
to the EM map, i.e., not being directly shaped by MDFF. For proteins at the exterior of the ribosome,
GBIS MDFF produces higher quality structures than in vacuo MDFF, because these proteins are
highly exposed to solvent and, therefore, require a solvent description. The structural improvement
for several exterior solvated proteins, calculated by RMSDvac,exp(3 ns)− RMSDimp,exp(3 ns), is 3.5 A˚
, 2.4 A˚ and 1.6 A˚ for ribosomal proteins S6, L27 and S13 (highlighted red in Figure 3.1), respectively.
Accurate modeling of these proteins is critical for studying the translation process of the ribosome.
The L27 protein, for example, not only facilitates the assembly of the 50S subunit, it also ensures
proper positioning of the new amino acid for peptide bond formation [112]. The S13 protein, located
at the interface between subunits, is critical to the control of mRNA and tRNA translocation within
the ribosome [113].
The use of GBIS for MDFF also increases structural quality in regions where the EM map does
not resolve the ribosome’s structure and, therefore, MDFF does not directly influence conformation;
though it is most important that MDFF correctly models structural regions defined in the EM map,
it is also desirable that it correctly describes regions of crystal structures not resolved by the EM map.
The structural improvement, over in vacuo MDFF, of the unresolved segments is 8.3 A˚ for mRNA and
4.9 A˚ for L12 (highlighted red in Figure 3.1). The L12 segment is a highly mobile ribosomal protein in
the 50S subunit that promotes binding of factors which stabilize the ratcheted conformation; L12 also
promotes GTP hydrolysis which leads to mRNA translocation [114]. As clearly demonstrated, the
use of GBIS MDFF, instead of in vacuo MDFF, improves the MDFF method’s accuracy for matching
crystallographic structures to EM maps, particularly for highly solvated or unresolved proteins.
27
To compare computational performance of the solvent models for MDFF, each ribosome simulation
was benchmarked on 1020 processor cores (3.5 GHz processors with 5 GB/s network interconnect); the
simulation speed for explicit solvent MDFF is 3.6 ns/day, for implicit solvent MDFF it is 5.2 ns/day
and for vacuum MDFF it is 37 ns/day. GBIS MDFF performs 50% faster than does explicit solvent
MDFF, but seven times slower than in vacuo MDFF. NAMD’s GBIS implementation is clearly able
to achieve a more accurate MDFF match of the ribosome structure (see Table 3.1) than does an in
vacuo MDFF calculation and does so at a lower computational cost than explicit solvent MDFF.
3.3 Discussion
The generalized Born implicit solvent (GBIS) model has long been employed for molecular dynamics
simulations of relatively small bio-molecules. NAMD’s unique GBIS implementation can also simulate
very large systems, such as the entire ribosome, and does so efficiently on large parallel computers.
The new GBIS capability of NAMD offers a great further advance to the MDFF method by furnishing
the necessary description of solvent environment while avoiding inclusion of a huge number of water
molecules into MDFF simulations. Moreover, the absence of explicit water molecules eliminates the
viscosity imposed on simulated solutes, effectively allowing faster equilibration of solute conforma-
tions and better conformational sampling and, hence, speeding up conformational changes in MDFF
simulations.
3.4 Methods
Generalized Born implicit solvent model
A theoretical description of the generalized Born implicit solvent model is provided in Appendix A.
MDFF simulations of the ribosome
The classical state in our simulations is an all-atom ribosome structure [16] with 50S and 30S subunits
taken from PDB IDs 2I2V and 2I2U, respectively [115], and the complex fitted to an 8.9 A˚ resolution
classical state EM map [45]. In the multistep protocol for fitting this classical state ribosome to a
ratcheted state map [3], the actual ribosome is fitted first, followed by fitting the tRNAs. Since the
fitting of the ribosome itself exhibits the largest conformational changes (inter-subunit rotation and
L1-stalk closing), we limit our MDFF calculation here to the ribosome and do not include tRNAs.
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Three MDFF simulations were performed using NAMD [11] and analyzed using VMD [116]. The
MDFF simulations are carried out in explicit TIP3P [32] solvent, in implicit solvent and in vacuo.
All simulations were performed in the NVT ensemble with the AMBER99 force field [117], employing
the SB [118] and BSC0 [119] corrections and accounting for modified ribonucleosides [120]. The grid
scaling parameter [4], which controls the balance between MD force field and the EM-map derived
force field, was set to 0.3. Simulations were performed using a 1 fs timestep with nonbonded forces
being evaluated every two steps. Born radii were calculated using a cutoff of 14 A˚, while the nonbonded
forces were smoothed and cut off between 15 and 16 A˚. An implicit ion concentration of 0.1 M was
assumed with protein and solvent dielectric set to 1 and 80, respectively. A Langevin thermostat with
a damping coefficient of 5 ps−1 was employed to hold the temperature to 300 K. In the explicit solvent
simulation, the ribosome was simulated in a periodic box of TIP3P water [32] including an explicit ion
concentration of 0.1 M, with nonbonded forces cut off at 10 A˚ and long-range electrostatics calculated
by PME every four steps. The in vacuo simulation utilized the same parameters as explicit solvent,
but without inclusion of solvent or bulk ions, and neither PME nor periodicity were employed.
Each system was minimized for 5000 steps before performing MDFF for 3 ns. For the explicit
solvent simulation, an additional 0.5 ns equilibration of water and ions was performed, with protein
and nucleic acids restrained, before applying MDFF.
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Chapter 4
Cryo-EM Modeling Challenge 2010
Reproduced in part with permission from Kwok-Yan Chan, Leonardo G. Trabuco, Eduard Schreiner,
and Klaus Schulten. Cryo-electron microscopy modeling by the molecular dynamics flexible fitting
method. Biopolymers, 97:678-686. Copyright 2012 John Wiley and Sons.
4.1 Introduction
Cryo-electron microscopy (cryo-EM) is furnishing images of biological complexes for over 30 years [121].
Continuous progress in instrumentation and methodology has consolidated cryo-EM as a major
biomolecular structure determination technique, especially for large macromolecular complexes, the
crystallization of which is typically too challenging. Cryo-EM single-particle reconstruction yields
now routinely structures at sub-nanometer resolution, in some cases approaching atomic resolu-
tion [76, 122, 123, 124, 125, 126, 127, 128]. Even though de novo modeling of atomic structures
is now possible in exceptional cases, interpretation of cryo-EM maps typically leverages available
crystallographic structures. Approaches to merge structural information of different modalities are
collectively called hybrid methods, and are in fact analogous to methods employed for X-ray structure
determination. Electron density maps solved by X-ray crystallography at ∼3 A˚ resolution, for instance,
clearly do not feature atomic resolution per se, but since the structure of the building blocks (mainly
amino acid residues and nucleotides) is known at very high resolution, complete atomic models can
be built given such electron density maps.
A number of hybrid methods that combine structural information from X-ray crystallography and
cryo-EM have been proposed in the last few years (see Chapter 2 and Trabuco et al. [4]), including
the molecular dynamics flexible fitting (MDFF) method [3]. Evaluation of the performance of various
hybrid approaches in a systematic way is highly desired in the cryo-EM community. Therefore the
Cryo-EM Modeling Challenge 2010 was held in which developers of different hybrid methods applied
their methods to model the same set of cryo-EM maps and deposited the resultant structures onto a
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public-accessible server [34].
As part of the Cryo-EM Modeling Challenge 2010 (http://ncmi.bcm.edu/challenge), we have
applied MDFF to a number of density maps, namely: GroEL (4 A˚), GroEL-GroES complex (7.7 A˚),
Mm-cpn in its closed state (4.3 A˚), lidless Mm-cpn in its open state (8 A˚), aquaporin-0 (2.5 A˚, electron
crystallography), VP6 component of rotavirus (3.8 A˚), and a bacterial ribosome (6.4 A˚). Below we de-
scribe the atomic models obtained with special emphasis on tools to detect and prevent stereochemical
errors and application of MDFF to crystallographic data.
4.2 Results
Figure 4.1: Atomic models obtained by applying MDFF to density maps from the Cryo-EM Modeling Challenge 2010:
(A) GroEL; (B) GroEL-GroES complex in the ATP-bound state; (C) Mm-cpn in the closed state; (D) lidless Mm-cpn
in the open state; (E) aquaporin 0; (F) VP6 component of rotavirus; and (G) a bacterial ribosome.
Atomic models were obtained by applying MDFF to seven density maps provided in the Cryo-
EM Modeling Challenge 2010 (Fig. 4.1). In order to assess the quality of the fit for each case,
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the cross-correlation coefficient (CCC) between initial/final structures and the corresponding maps
was calculated, showing an improvement in all cases (Table 4.1). The classical CCC suffers from
an important limitation: all volume within the box encompassing the density map is taken into
account in the calculation, such that a significant portion of the data points used does not actually
correspond to the macromolecule [3, 4]. In fact, a CCC coefficient close to one can be obtained
simply by defining a sufficiently large bounding box. Furthermore, in cases where only a subset of
the macromolecular components imaged can be modeled, the unoccupied regions in the map lead
to a lower global CCC. Thus, it is usually preferable to use a local CCC measure, in which only
regions around the macromolecule are used in the calculation. Initial and final local CCCs presented
in Table 4.1 show more clearly the improvement of the fit obtained by employing MDFF simulations.
Table 4.1: Local and global cross-correlation coefficients (CCC) between atomic models and density maps. Local CCCs
were calculated using a density threshold of 1 and 0.2 standard deviation above the mean for maps with resolution
higher and lower than 5 A˚, respectively. Global CCCs are given in parentheses.
System Resolution Initial Final
Aquaporin 2.5 A˚ 0.58 (0.34) 0.69 (0.39)
GroEL 4 A˚ 0.32 (0.74) 0.57 (0.86)
GroEL-GroES 7.7 A˚ 0.44 (0.84) 0.71 (0.90)
Rotavirus 3.8 A˚ 0.68 (0.56) 0.75 (0.61)
Mm-cpn in closed state 4.3 A˚ 0.51 (0.74) 0.59 (0.76)
Mm-cpn in open state 8 A˚ 0.15 (0.39) 0.77 (0.88)
Ribosome 6.4 A˚ 0.30 (0.75) 0.46 (0.80)
Stereochemical errors
Force fields used in MD simulations do not contain any energy term designed to enforce a given chi-
rality or cis/trans peptide bond configuration. In general, both enantiomers or peptide bond isomers
can arise, although the two forms are separated by a large energy barrier. Thus, for equilibrium
MD simulations starting with error-free atomic structures, stereochemical errors are not expected to
arise. In simulations such as MDFF employing external forces, however, it is possible for artifactual
chirality or peptide bond configurations to arise, resulting in an atomic model with stereochemical
errors. Hybrid methods do apply forces to atoms to drive them into the EM density map and, thus,
may introduce stereochemical errors, unless additional measures are taken. To ensure stereochemical
integrity of molecular models, software tools were developed to identify, visualize, and interactively
correct stereochemical errors in biomolecular structures [129]. These tools are implemented as two
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plugins (Chirality and Cispeptide) to the molecular visualization and analysis package VMD [116].
Given a stereochemically correct starting structure, the plugins can also be used to generate harmonic
restraints designed to prevent stereochemical errors from arising. Such stereochemical restraints are
included indeed in standard MDFF protocols. Practical details about use of the Chirality and
Cispeptide plugins are covered in Schreiner et al. [129], and in a tutorial available on the MDFF web-
site (http://www.ks.uiuc.edu/Research/mdff). Since the data of these stereochemical restraints
are written out as files for input to the simulation package NAMD [11], they can also be utilized by
other MD simulation packages that support user-defined internal-coordinate restraints after adapta-
tion of the data files.
During the Cryo-EM Modeling Challenge 2010, atomic models obtained by different flexible fitting
methods were deposited and made publicly available. Analysis of such models can help answer the
question of whether hybrid methods not based on MD simulations are also prone to introducing
stereochemical errors in the generated atomic models. Table 4.2 presents the number of chirality
errors and cis peptide bonds identified by the Chirality and Cispeptide VMD plugins, respectively,
for each deposited atomic model obtained with a flexible fitting method, covering a total of five different
methods. Structures derived with MDFF or Rosetta [130] were stereochemically correct, whereas the
other three investigated methods (DireX [55], Gorgon [125, 131], and Froda [132, 133]) introduced
stereochemical errors. The different stereochemical quality of models may stem from the different
definition of allowed configurations and the usage of additional restraints in the various methods.
Table 4.2: Chirality errors and cis peptides identified in atomic models obtained by various flexible fitting methods,
deposited as part of the Cryo-EM Modeling Challenge 2010. The number of chirality errors is given first, followed by
the number of cis peptide bonds. For rotavirus and ribosome, 3 and 6 cis peptides, respectively, involving Pro present
in the original structures were not considered. Mm-cpn models obtained by Gorgon contain only a single unit, so the
total number stereochemical errors can be obtained by multiplying the given values by 16. Cases for which a model was
not deposited are identified with n/a.
System Resolution MDFF DireX Rosetta Gorgon Froda
Aquaporin 2.5 A˚ 0, 0 0, 0 0, 0 n/a n/a
GroEL 4 A˚ 0, 0 0, 4 0, 0 n/a n/a
GroEL-GroES 7.7 A˚ 0, 0 194, 60 0, 0 n/a 14, 11
Rotavirus 3.8 A˚ 0, 0 0, 1 n/a n/a n/a
Mm-cpn closed state 4.3 A˚ 0, 0 0, 0 0, 0 244, 202 n/a
Mm-cpn open state 8 A˚ 0, 0 n/a 0, 0 267, 257 694, 115
Ribosome 6.4 A˚ 0, 0 n/a n/a n/a n/a
Apart from peptide bond configuration and chirality, the stereochemical quality of structures can
be addressed by comparison with available crystal structure data and structure validation tools like
33
Molprobity [134]. Here, we chose the 3.8-A˚ map of the VP6 component of rotavirus to compare
with the crystal structure and analyze the comparison with Molprobity. The crystal structure used
for comparison is the same as the starting structure used for the fitting (PDB 1QHD [123]). The
RMSD between the heavy atoms of the crystal structure and the MDFF model is 1.17 A˚, showing
close resemblance of the MDFF model to the high-resolution (1.95 A˚) crystal structure. Some degree
of deviation should be expected due to different molecular environments of the models, i.e., a crystal
and a solution environment. Another reason for a significant RMSD value may be a superposition of
different conformers present in the cryo-EM map.
An alternative comparison between MDFF model and crystal structure is furnished by backbone
dihedrals. The main advantage of using the RMSD between these internal coordinates is that it does
not rely on any alignment. Taking all backbone dihedrals into account, the RMSD for the Φ and Ψ
angles are both about 21 degrees. Excluding flexible loop regions from the comparison yields RMSDs
of 2 and 2.6 degrees for the Φ and Ψ angles, respectively. The reduced RMSD clearly shows that most
of the differences stem from the loop regions. Apart from the fact that secondary structure elements
were kept restrained during MDFF, a dominant uncertainty in the positions of loop regions should be
expected since these regions are less resolved in the EM data and very flexible in MD simulations.
Table 4.3: Comparison of stereochemistry of initial structure, final structure and structure after further minimization
without EM data for the map of VP6 component of rotavirus (3.8 A˚) as analyzed by the Molprobity web server [134].
Definitions of the stereochemistry indicators are covered in Chen et al. [134]
Stereochemistry indicators Initial Final Minimized
Clashscore 0.95 6.01 0.48
Poor rotamers 4.43% 9.49% 1.27%
Ramachandran outliers 0% 3.85% 0.26%
Ramachandran favored 97.44% 87.44% 96.67%
Cβ violations 9 101 2
Residues with bad bonds 0% 16.33% 0%
Residues with bad angles 0% 11.48% 0.26%
Although no stereochemical errors were detected in the final fitted structure of the VP6 component
of rotavirus, the Molprobity server detected differences relative to the crystal structure. Overall,
the MDFF-derived model shows a larger degree of flexibility than observed for the crystal structure
(Table 4.3). The origin of the differences is of the same nature as already discussed for the comparison
of RMSD in real space. The obtained differences are observed even after a short structure optimization
(see Methods for the simulation protocol), suggesting that the variation in structural parameters is
compatible with the map and moreover is within a reasonable range as guaranteed by the force field.
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A more aggressive optimization using tighter convergence criteria and not taking into account the EM
data would be able to reduce even more deviations from the ideal values (Table 4.3). This means,
however, that the effect of the temperature, which is present in the EM map, will be eliminated.
Application to electron crystallography
The MDFF method had been developed and validated initially as a real-space refinement method
for cryo-EM density maps [3]. Since the Cryo-EM Modeling Challenge 2010 provided a density map
obtained by electron crystallography (aquaporin-0 resolved at 2.5 A˚), the applicability of MDFF to
such data source was tested. The originally solved structure (PDB 3M9I [135]) was thus refined
with MDFF. For the purpose of the challenge, which focuses on obtaining structural models based
on cryo-EM data, the density map was treated only as an EM map and kept unchanged throughout
the refinement process. As a proof-of-principle, a very simple measure was defined to determine if
MDFF could potentially provide qualitative improvements. A molecular envelope was defined using
a density threshold and, for each residue in the atomic model, the fraction of heavy atoms inside the
envelope was calculated before and after MDFF refinement (Fig. 4.2A). Overall, MDFF lead to an
increase in the fraction of atoms inside the molecular envelope. Focusing on a few peaks from the plot
in Fig. 4.2A, one can visually inspect the effect of MDFF on the local structure at the side chain level
(Fig. 4.2B-E). The images show that, in principle, MDFF refinement has the potential to improve the
quality of structures solved by electron crystallography.
Figure 4.2: MDFF applied to a 3-A˚ electron crystallography map of aquaporin 0. (A) Per-residue fraction of heavy
atoms inside a molecular envelope defined by a density threshold of one standard deviation above the mean. Examples
of residues with improved placement of side chains within the density, as identified by peaks in the plot, with initial
structure colored in red: (B) Arg-11; (C) Phe-18; (D) Phe-136; and (E) Asn-197.
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It should be noted, however, that in crystallographic refinement the phases and, hence, the density
map are updated iteratively. Furthermore, one could utilize information like beta factors or even the
original diffraction data in the MDFF fitting process. Despite the stated shortcomings, improvement
of structure by refinement to a static map showcased here suggests the possibility to develop an
extension of MDFF to fit crystallographic data, which is indeed under development [136].
4.3 Discussion
MDFF was applied to obtain atomic models for several density maps determined by the Cryo-EM
Modeling Challenge 2010, covering a range of system sizes (single proteins to large complexes) and
resolutions (2.5–8 A˚). A comparative analysis of atomic models obtained using different flexible fitting
methods revealed that certain approaches are prone to introducing stereochemical errors. MDFF
protocols include extra harmonic restraints designed to prevent such errors from arising [129].
MDFF benefits from the flexibility of NAMD, its underlying MD package [11], as highlighted by
the aforementioned examples. As the MDFF method matures and is applied to a larger range of
systems, limitations can often be addressed by introducing special-purpose restraints, such as the
ones designed to preserve symmetry [5] or stereochemical correctness [129]. Being part of the very
efficient NAMD software, MDFF also benefits from NAMD’s high scalability, which is almost linear
with system size and number of CPUs. For example, the solvated VP6 component of the rotavirus
in the challenge is comprised of 105,537 atoms and the MDFF simulation speed was about 0.66 days
per ns using 48 CPUs, while the larger GroEL-GroES system in solvent consists of 594,845 atoms
and the speed was about 3.79 days per ns using 48 CPUs, showing almost linear scaling with system
sizes. Speed and number of cores required by systems of other sizes should be approximately equal
to linear interpolation of these numbers. For instance from linear interpolation of the above numbers
one would expect to get about 3.8 days per ns on an eight-core machine for a system of 100,000
atoms. This scalability makes MDFF applicable even to very large systems. In light of ever increasing
computational power, computational cost should not be a barrier to the use of MDFF.
Since MDFF is based on MD simulations, any molecule that has been parameterized in MD force
fields can be modeled by MDFF. Macromolecules can also be modeled in a realistic environment,
namely solvated by water molecules and ions, or even embedded in a lipid membrane [137, 138, 4]. The
current release of NAMD 2.8 supports the generalized Born implicit solvent model [6]. Calculations
using implicit solvent models reduce the computational cost by avoiding computations associated
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with water, which comprises often the largest part of the system. MDFF results obtained with the
Born model were shown to provide better agreement with the corresponding results in explicit solvent
than in-vacuo fittings [6]. Since the implicit solvent feature was not yet available at the time of the
challenge, the benefits cannot be showcased here. Readers are referred to Chapter 3 and Tanner et
al. [6] for more information on implicit-solvent MDFF.
The Cryo-EM Modeling Challenge 2010 was the first community effort to evaluate the performance
of different hybrid methods in a systematic way. Structural biologists wishing to apply hybrid methods
now have more information to decide which approach is most appropriate to their particular problem.
Although concrete conclusions are not made in this first attempt of the challenge, it is expected that
the next challenge will provide more information for potential users of hybrid methods. Such efforts
also motivate researchers to push the boundaries of their methods by applying them to new kinds of
problems. As an example, the first proof-of-principle application of MDFF to crystallographic data
resulted from the challenge. The hybrid modeling field as a whole stands to benefit greatly from
such community efforts. Method developers can learn from each other and further improve their
own methods in an iterative way, and opportunities arise for combining multiple methods to tackle
modeling tasks of ever increasing difficulty.
4.4 Methods
The following structures were used as the starting point for the MDFF simulations presented in this
paper: PDB 3E76 [139] was fitted into the 4-A˚ GroEL map [122]; PDB 2C7D [71] was fitted into
the 7.7-A˚ GroEL-GroES map [71]; PDB 3LOS [76] was fitted into the 4.3-A˚ map of Mm-cpn in a
closed state [76]; a homology model of a lidless Mm-cpn complex was built with Modeller [140] using
PDB 3LOS as a template and fitted into the 8-A˚ map of lidless Mm-cpn in an open state [76]; PDB
3M9I [135] was fitted into the 2.5-A˚ aquaporin 0 map [135]; PDB 1QHD [141] was fitted into the
3.8-A˚ map of a VP6 component of rotavirus [123]; and PDB 2WDG/2WDI [142] was fitted into the
6.4-A˚ ribosome map [143] after removing bound factors. Each structure was first rigid-body docked
into the corresponding density maps using colores from the Situs package [51].
Aquaporin-0 was embedded in a POPE lipid bilayer of size 100 A˚× 100 A˚, with TIP3P [32] water
molecules added with a 15-A˚ padding in the direction orthogonal to the membrane. The ribosome
system was simulated in vacuo, whereas the remaining structures were solvated in a TIP3P water box
with a 10-A˚ padding in all directions. All systems simulated in explicit solvent had their total charge
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neutralized by adding Na+ or Cl− ions.
MD simulations were performed with a development version of NAMD 2.8 [11]. The CHARMM27
force field with CMAP corrections [79, 80] was used for all systems except for the ribosome, which
was simulated with the AMBER99 force field [117] including the SB [118] and BSC0 [119] corrections,
and converted to CHARMM format [16] to allow for system building with VMD [116]. The dielectric
constant was set to 80 for the ribosome simulation in vacuo and to 1 for the remaining systems.
Temperature was maintained at 300 K using Langevin dynamics with a damping constant of 5 ps−1.
For the aquaporin system (embedded in a membrane), pressure was maintained at 1 atm employing
a Nose´-Hoover-Langevin piston with a decay period of 200 fs and time constant of 100 fs. The
RESPA [81, 82] multiple-time-stepping algorithm was used with an integration time step of 1 fs,
short-range forces calculated every 2 fs, and long-range electrostatics calculated every 4 fs. Nonbonded
interactions were calculated with a 10-A˚ cut-off. Long-range electrostatic forces were computed by the
particle-mesh Ewald summation method using a grid spacing smaller than 1 A˚. All systems simulated
in explicit solvent were subjected to restrained MD simulations prior to flexible fitting, with harmonic
restraints first applied to all protein atoms, followed by restraints applied only to backbone atoms,
thus allowing water, ions, lipids (in case of aquaporin), and side chains to equilibrate.
The grid scaling, an MDFF parameter that controls the balance between the map-derived potential
energy term and the normal MD force field, was set to 0.3 [3]. Harmonic restraints were applied to
enforce correct chirality and peptide bond configuration [129]. Each MDFF simulation was performed
until convergence of the protein RMSD, followed by 3,000 steps of energy minimization in the presence
of the density-derived MDFF energy term and a grid scaling of 10. For symmetry-restrained MDFF
simulations [5], only Cα atoms experienced symmetry restraints, with the force constant linearly
increased from 0 to 10 kcal/mol/A˚2 throughout the simulations.
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Chapter 5
Mechanism of tetracycline
resistance by ribosomal protection
protein Tet(O)
Reproduced in part with permission from Wen Li, Gemma C. Atkinson, Nehal S. Thakor, U¨lar Allas,
Chuao-chao Lu, Kwok-Yan Chan, Tanel Tenson, Klaus Schulten, Kevin S. Wilson, Vasili Hauryliuk,
and Joachim Frank. Mechanism of tetracycline resistance by ribosomal protection protein Tet(O).
Nat. Commun., 4:1477. Copyright 2013 Nature Publishing Group.
5.1 Introduction
Tetracycline (Tc) is a broad-spectrum antibiotic active against both gram-positive and gram-negative
bacteria, and used in a variety of medical and veterinary applications [35]. It targets the small subunit
of the bacterial ribosome [144], with the primary high-affinity binding site located beneath helix 34
of the 16S rRNA, in a crevice between head and platform of the 30S subunit, in close vicinity of the
A-site codon [144]. In this binding site, Tc partially occupies the space where an aminoacyl-tRNA
would approach the A-site codon during the decoding process. Thus, Tc binding prevents any entering
aminoacyl-tRNA from being recognized by the codon in the messenger RNA and thereby incapacitates
the ribosome for protein synthesis [145].
Resistance to Tc is mediated through one of several mechanisms: Tc eﬄux, protection of the
Tc binding site by binding of specific cytoplasmic proteins to the ribosome, Tc modification, or
modification of 16S rRNA at the Tc-binding site [146]. These mechanisms are facilitated by over 20
different groups of tetracycline-resistance proteins [147]. Several of these proteins - the best-known
being Tet(M) and Tet(O) - are paralogs of the translational GTPase EF-G [148] and actively remove
Tc from the ribosome in a GTP-hydrolysis-dependent fashion [36, 37].
Detailed information on the Tet(O)-induced conformational changes of the ribosome to disrupt
Tc binding is essential for understanding their mechanism of action. A previous Tet(O) cryo-EM
study [149], with a density map at a resolution of 16 A˚, allowed the visualization of Tet(O) bound
to the Escherichia coli ribosome, revealing that Tet(O) indeed has a similar shape as EF-G and
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binds to the same general site within the intersubunit cavity of the ribosome. Overall, the ribosomal
complex was seen to closely resemble the conformation of the EF-G-70S ribosome complex stabilized
with GDPNP. Sequence homology shows that Tet(O) shares the five structural domains with EF-G,
the first two containing the GTP-binding site and being close to the GTP-associated center of the
50S ribosomal subunit, while the other three domains are distinct for Tet(O) and associated with its
specific functions [149, 150].
The high degree of sequence homology shared by Tet(O) and EF-G [151] makes it possible to build
an atomic model of Tet(O) based on the X-ray structure of EF-G, using a cryo-EM map as constraint,
provided its resolution is sufficient. The existing 16-A˚ reconstruction of Tet(O)-70S [149] is unsuitable
for this purpose. In this study, we obtained an improved cryo-EM map of the E. coli 70S ribosome
in complex with GDPNP-bound Tet(O) from Campylobacter jejuni, the best characterized ribosomal
protection protein, with a resolution of 9.6 A˚. Guided by this higher-resolution map, a map-fitted
atomic model of the ribosome-Tet(O) complex has allowed us to determine the binding sites between
Tet(O) and the ribosome. Our results indicate that the critical residues of Tet(O) would clash with Tc
if both were present in the same ribosome complex; thus the presence of Tet(O) is poised to disrupt
the binding of Tc. These critical residues are located in three loops of domain 4, whose positions with
respect to the ribosome are different than for EF-G [152]. Moreover, our structural results are strongly
corroborated by our mutational and biochemical data. Multiple tests of the three Tet(O)’s loops with
either a single Ala mutation in one of the three loops, or a replacement of any of the three residues
tipping the three loops by a glycine, resulted in loss of Tet(O) functionality as measured by minimum
inhibitory concentration (MIC) of the antibiotic resistance of E. coli strains. Together, these results
allow us to understand the structural basis for the Tc-resistance mechanism on the molecular level.
5.2 Results
Cryo-EM density map of Tet(O) bound with the 70S ribosome
We obtained a three-dimensional cryo-EM density map for the complex of Tet(O) bound with the
70S ribosome in the presence of the nonhydrolyzable GTP analog GDPNP at a resolution of 9.6 A˚.
The density for Tet(O) in this improved map is at a position which agrees with that described in the
earlier study [149], but boundary and shape are better defined in the context with the 70S ribosome
(Fig. 5.1).
To date, Tet(O)’s structure has not been solved by crystallography. In the present study, the
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Figure 5.1: Cryo-EM maps of the 70S ribosome from E. coli bound with Tet(O). (a) 70STet(O)GDPNPfMet-tRNA
complex. The map is segmented to show the 30S subunit (yellow), the 50S subunit (blue), Tet(O) (red) and the P-site
tRNA (green). The same color scheme is used for panels (a)-(c). (b) Density for the 30S subunit with Tet(O) and P-site
tRNA. (c) Density for the 50S subunit with Tet(O) and P-site tRNA.
improved resolution of the density map allowed us to build an atomic model of Tet(O), guided by
its homology to EF-G, and characterize its binding interactions with the ribosome. First, a sequence
alignment of C. jejuni Tet(O) and Thermus thermophilus EF-G was created, guided by the crystal
structure of EF-G (PDB accession code: 2WRI) using the 3D-coffee software [153]. To compare
site-specific sequence conservation across the entire Tet(O) and EF-G families, a dataset of sequences
belonging to both of these families was assembled. Tet(O) sequence homologs, representing the Tet
family of translational GTPases (trGTPases), were retrieved from the NCBI using BlastP. These
sequences were aligned with a dataset of previously identified sequences from the EF-G family [154],
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and consensus sequences were generated for each family. The sequence alignment results indicate a
high sequence similarity (50%) between Tet(O) and EF-G, a firm basis for using homology modeling.
In all these sequences, the highly conserved nucleotide-binding motifs are perfectly aligned, and the
sequence of Tet(O) is divided into five domains, corresponding to the domains defined by the sequence
of EF-G. The alignment of C. jejuni Tet(O) and T. thermophilus EF-G was used to create a homology
model of Tet(O) using the program Modeller [155].
Our model of Tet(O) closely resembles the structural features of EF-G which is in a 70S ribosome-
bound GTP form (Fig. 5.2). The Tet(O) model together with the X-ray structure of the 70S ribo-
some [156] was fitted into the entire cryo-EM map for the complex using the Molecular Dynamics
Flexible Fitting method [4]. The fitted structure, as shown in Fig. 5.3, closely captures the con-
formation of the entire complex as formed in the density map, which allows us to characterize the
interactions between Tet(O) and the ribosome in detail. We validated the fitting structure by using a
different crystal structure of the 70S ribosome as the starting structure for the MDFF (2WRI, 2WIJ).
The resultant structure of Tet(O) as well as the bases re-arrangement in the 16S rRNA are in good
agreement with the model presented here. The RMSD of the two 70S ribosomal structures is just
1.5 A˚, and just 1.7 A˚ for all atoms of Tet(O).
Figure 5.2: Homology model of Tet(O). (a) The initial Tet(O) model (red) and the EF-G structure ((green, PDB code:
2WRI) are shown as overlaid ribbons in the segmented density map (red mesh). The three loops in domain IV are seen
to be positioned differently in the two structures. (b) The map-fitted structure of Tet(O) (red) is superimposed with
the crystal structure of EF-G, showing the adjustment in the orientations of the three loops of Tet(O) into the density
through the map fitting process.
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Interactions between Tet(O) and the ribosomal 30S subunit
Figure 5.3: Cryo-EM map-fitted atomic model of the 70S ribosome bound with Tet(O). (a) Cryo-EM map, displayed
as transparent mesh, with atomic model displayed as ribbons. The 16S rRNA is in yellow, proteins in the 30S subunit
in green, 5S and 23S rRNA in blue, and proteins in the 50S subunit in pink. Tet(O) is in red, P-site tRNA in dark
green. (b) The 30S subunit with Tet(O) and P-site tRNA shown in (a) is displayed after a clockwise rotation around
vertical (in plane) axis by 90◦, to show the interface with the 50S subunit. (c) Tet(O)’s domain IV (red), superimposed
with the anticodon stem and loop of an A/T-site tRNA (grey) in the decoding region of the 30S subunit. The overlap
between Tet(O) and the tRNA occurs at the 507- and 438-loops. (d) Zoomed-in view of the area marked by green box
in (b). (e) Portion of the 16S rRNA (pink) surrounding Tc, superimposed on the 16S rRNA (yellow) in the current
Tet(O)-bound model. The 507-loop is seen to clash with the site for Tc (blue). Nucleotides 1051 and 1054 in the 16S
rRNA are seen to be re-oriented in the two structures. (f) The 507-loop, 438-loop and a portion of the 30S subunit
including nucleotides 966, 1196 and their surrounding nts form a structural corridor for a possible release of Tc. (g)
Tet(O)-S12 contact sites. S12 is shown in dark green.
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Tet(O) binds with the ribosome on both the 30S and 50S subunits. On the 30S subunit, the three
loops in domain IV of Tet(O), namely the 465- , 507- and the 438-loop, insert into the head-platform
crevice, spanning across about 30 A˚ (Fig. 5.3c-d). The large spatial expansion of the three loops may
allow them to play various roles in their binding with the ribosome, in jointly conveying Tc resistance.
The 507-loop and the 438-loop occupy approximately the position where the anticodon stem-loop of
an A-site tRNA would occur in a normal translating ribosome, while the 465-loop extends into the
structural pocket formed between nucleotides 1055 and 1209 within helix 34 (Fig. 5.3c). Although this
third loop is placed outside the decoding center at the A site, it apparently plays a role in restraining
the structural flexibility between the 1055 and 1029 ends.
The 507-loop, which is located in the middle of the lined-up three loops, appears to have the most
direct, and most crucial role in bestowing tetracycline resistance as evident from its position relative
to Tc. The position of Tc in the 30S subunit, as revealed by the crystallographic study [144], was
mapped to the current structure of the 30S subunit (Fig. 5.3e). This position would result in a spatial
clash between residues 507-509 and Tc if both were present in the same complex, i.e., either Tc or the
Tet(O)’s 507-loop would exclusively occupy the same space. Unlike the 507-loop, the 438-loop is not
involved in the interactions with Tc, located about 15 A˚ away from Tc, but residue 437 is located in
the near vicinity of nucleotides 1492-1493 in the 16S rRNA, where the decoding interaction network
is observed in a normal translation ribosome [157]. We observe that this loop and nucleotides around
966 and 1196 of the 16S rRNA with their surrounding nucleotides form a corridor, which starts at the
position of Tc and leads to the outside of the ribosome (Fig. 5.3f). The dissociating Tc molecule has
to navigate this corridor, which acts as the only pathway for the molecule’s release from the ribosome,
which might explain the high activation energy of the process [37].
The presence of the 465-loop inside the structural pocket near nucleotides 1051 and 1209 in the
16S rRNA leads to a local distortion of the 16S rRNA, in the immediate vicinity of the Tc-binding site
(Fig. 5.3d). According to the Tc-bound 30S subunit, this loop occupies the position of nt 1209. The
presence of the 465-loop of Tet(O) at the base of the 30S subunit’s beak prevents the head of the 30S
subunit from rotating, a motion required in the normal course of mRNA-tRNA translocation [149].
Tet(O) interacts with the 30S subunit protein S12 closely at domain III, and possibly at domain
IV of Tet(O) (Fig. 5.3g). Residues 358 and 379 in domain III of TetO seem to be directly to interact
with S12’s residues 74-76. The S12 residues 483 and 517 are located at the base of the 507- and
465-loops of Tet(O), respectively. This interaction between S12 and Tet(O) at multiple sites is similar
to the bridge-like connection that S12 forms with two sites of the A/T-site tRNA in the EF-Tu-tRNA
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complex, as previously described for the X-ray structure of the ternary complex-bound ribosome
complex [158].
It is worth noting that the Tet(O) 438-loop is located close to the mRNA around the A-site codon,
as shown in our map-fitted structure. The point of closest approach (within 3 A˚) occurs between
residue 438 and the second nucleotide for the A-site codon.
Functional importance of Tet(O) domain 4 loops
We validated our structural results by testing the effects of mutations of Tc-interacting regions on
Tet(O) functionality in vivo, as judged by measuring the antibiotic resistance of E. coli strains trans-
formed with plasmid-expressed Tet(O) mutants. These mutations and deletions were targeted in the
three characteristic loops in domain 4 of Tet(O), at those residues that are either directly or closely
involved in the interactions in the Tc-binding site. The effects of the mutations and deletions on
Tet(O) functionality were measured through the reduction in the minimum inhibitory concentration
(MIC) in each case.
Table 5.1: Inhibition of Tet(O) activity in mediating resistance by different mutations.
Loop Mutation Inhibition of Tet(O) activity (in %)
507-loop
Y507A 83
YSP507-509G 100
465-loop
L466A 33
S472A 67
LGY466-468G 100
438-loop
P438A 83
VPP436-438G 100
The results of the mutation experiments are presented in Table 5.1. All mutations in the three
characteristic loops, namely the 507-loop, the 465-loop and the 438-loop, resulted in significant in-
hibition of Tet(O)-mediated resistance. These results demonstrate that the integrity of the residues
identified in our cryo-EM reconstruction as binding sites is crucial for Tet(O) functionality. The
mutation results are fully consistent with our cryo-EM structural analysis.
Interactions between Tet(O) and the ribosomal 50S subunit
On the 50S subunit side, Tet(O) contacts the GTPase-associated center, between residues 619-620 in
domain III and nucleotides 1066 in helix 43 of the 23S rRNA. The residues of Tet(O) responsible for
GTP hydrolysis form a similar structural pocket as in EF-G, which surrounds the sarcin-ricin loop
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(nts in the 2662-loop). It is in this pocket where the hydrolysis takes place. In the Tet(O) complex, the
closest distance is found to be between nucleotide 2663 and residue 40, about 4 A˚. The current map-
fitted structure would need to be slightly adjusted around the GDPNP-binding position if GDPNP
was included in the fitted structure. Interestingly, helix 69 of the 23S rRNA, which was repeatedly
found to be involved in the interactions with other ribosomal factors such as the EF-Tu-aminoacyl-
tRNA complex and EF-G [152, 158], is positioned beyond a bonding distance from Tet(O). The closest
point (nucleotide 1914) is about 6 A˚ away from Tet(O). Therefore, in the current Tet(O)-ribosome
complex, helix 69 has no direct involvement.
Tet(O) binding-induced conformational changes in 30S
The overall ribosome conformation displays no intersubunit rotation when Tet(O) is stalled on the
ribosome in the presence of GDPNP. Essentially, binding with GDPNP allows Tet(O) to remain in its
GTP form. This ribosome conformation agrees with the X-ray structure of the 70S ribosome bound
with EF-G-GDP-fusidic acid [152]. However, a notable change of ribosomal conformation occurs in a
rearrangement that was identified using chemical footprinting [159]. In the complex with Tet(O), the
backbone shape of helix 34 deviates from the normal structure as formed in the X-ray structures of
the 30S subunit either bound or unbound with Tc (Fig. 5.3e). This RNA fragment in helix 34 includes
a single-nucleotide bulge at 1051, as well as two unpaired nucleotides 1054-1055, and connects the rest
of helix 34 on the two ends. These unpaired nucleotides naturally provide structural flexibility, which
is evidently exploited in the binding of Tet(O) to the ribosome. Our structure shows that residue
507 in domain IV and nucleotide 1054 in helix 34 would spatially clash if the fragment of helix 34
remained in its normal position. Therefore, the binding of Tet(O) clearly causes a change in that
region of backbone.
Following the positional change in nucleotide 1209, the backbone shape of the fragment around
nt 1051 also must adjust. The base of nucleotide 1054 in particular seems to play a crucial role in
holding tetracycline on the ribosome based on the crystal structure by Ramakrishnan and coworkers
(PDB ID 1HNW, [152]). Tetracycline adheres to the 30S subunit through multiple hydrogen bonds
with nucleotide 1054. The position of nt 1054 in the current structure is re-oriented from being in the
Tc-bound ribosome, otherwise it would clash with the 507-loop in Tet(O).
Another Tet(O) binding-induced change in the ribosome occurs at helix 18, including nucleotide
530, which is crucially involved in the network of bases during the normal decoding process. The
Tet(O) residue 512-513 in the map-fitted structure are within bonding distance from nucleotides
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516-519 of helix 18. This clash is resolved by the re-orientation of nucleotide 516, which appears
in a twisted conformation of helix 18 in our map-fitted structure. In this unusual conformation of
helix 18, its nucleotide 530 is also reoriented. Evidently, the original orientation must be restored if
translation on the ribosome were to resume after the Tet(O) is released from the ribosome along with
Tc. The correction would have to be spontaneous after Tet(O) release. This subsequent untwisting
process, which we must assume as part of the bacterial rescue of the ribosome, indicates a substantial
flexibility of the structure of helix 18. In addition, the bases of nts 1492-1493 in the 16S rRNA flip out
toward the Tet(O)’s 438-loop (Fig. 5.3); the flipped-out conformation that was also observed when a
codon-anticodon recognition takes place in a translating ribosome [157].
5.3 Discussion
In this study, the structure of the 70S-Tet(O) complex in the presence of GDPNP has allowed us to
visualize the details of binding between the 70S ribosome and Tet(O). In the GDPNP-bound form
Tet(O) was earlier shown biochemically to promote release of Tc from the 70S ribosome [159, 160],
and the elucidation of the current structure therefore provides direct functional insights into the
mechanisms of Tet(O)-mediated Tc resistance.
On the 30S subunit side, Tet(O) is positioned close to the site where Tc has been found in the
X-ray structure. The 30S subunit-Tet(O) contact sites we have identified in the present study can be
divided into two categories: (1) those which lead to a clash with the space for the binding of Tc via
the 507-loop and (2) those which disrupt the structure of the 16S rRNA around the Tc-binding site
via the 465-loop toward nucleotide 1209 in 16S rRNA. As in EF-G, the GTP-binding site in Tet(O) is
located at the GTPase-associated center. These contacts between the Tet(O) and the ribosome seem
to collectively play the role of preventing or reversing the binding of Tc to the ribosome.
The most direct effect of Tet(O) binding in preventing Tc from binding to the 30S subunit seems
to be the result of a competition between residues 507-509 of Tet(O) and Tc for the same space.
When Tet(O) enters into the Tc-bound ribosome, the 507-loop cannot be settled into the ribosome
complex because Tc already occupies the close vicinity of nucleotide 1054 and forms multiple hydrogen
bonds with the ribosome. The competition for the same site guarantees that Tet(O) and Tc cannot
coexist in the ribosomal complex. In addition, binding of Tet(O) disrupts the ribosome structure
and reshapes the geometry of the backbone where Tc is anchored (Fig. 5.3e). With this disrupted
backbone structure, the nucleotides involved in binding with Tc are reoriented, and thus, Tc loses its
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bonds with the ribosome. Interestingly, the binding of Tc does not change the backbone shape from
its shape in the Tc-free ribosome.
The question arises is by which molecular mechanism Tc inhibits normal translation in the ribo-
some. One may ask why a Tc-bound ribosome does not accept an entering EF-Tu-bound aminoacyl-
tRNA complex, but does accept Tet(O) even though the EF-Tu-aminoacyl-tRNA complex forms a
shape highly similar to that of Tet(O). Our current study provides some insights to answer this ques-
tion. If an aminoacyl-tRNA bound with EF-Tu enters into the ribosome, its anticodon loop must reach
the codon site. In the presence of Tc, a primary portion of the space for the anticodon loop is already
occupied by Tc (Fig. 5.3e) which causes a decisive rejection of the aminoacyl-tRNA from the ribosome
before codon-anticodon recognition can take place. In contrast, Tet(O) enters the ribosome with less
demand for space in that region than the anticodon loop of the tRNA; the available space provides
an opportunity for Tet(O) to be admitted to the factor binding site, important for subsequence GTP
hydrolysis.
Tet(O), a GTPase, possesses a structure very similar to that of ribosomal GTPase, elongation factor
G. The structural similarity suggests an analogy of their GTP-hydrolysis-induced conformational
changes which enable the two ribosomal proteins to perform their respective biological functions.
The structural effects of the EF-G-associated GTP hydrolysis on the ribosome have been extensively
studied [161, 19, 162]. It is known that GTP hydrolysis induces substantial conformational changes
in the ribosome. The ribosome’s effect on the conformation of EF-G is substantial, as well, causing
domain IV to be reoriented relative to the other domains, as shown by cryo-EM [19] and X-ray
structures [152] of the ribosome bound with EF-G in the presence of fusidic acid. The antibiotic
fusidic acid traps EF-G in a conformational intermediate between the GTP and GDP forms. In this
translocational complex, a contact observed between the 507-loop of EF-G and the P-site tRNA seems
to be essential for the translocation of tRNA based on the significant conformational flexibility of this
loop [152]. This flexibility allows the loop to participate in the major dynamic motion of the entire
domain IV as the GTP hydrolysis takes place. Thus, we see this loop as a functionally required
structural element in EF-G. The structural similarity of Tet(O) to EF-G suggests structural flexibility
in the equivalently positioned loops of Tet(O). Accordingly, we predict that GTP hydrolysis in Tet(O)
results in extensive conformational changes in the distal loops of domain IV, particularly in the three
flexible loops. By combining structural and mutational analyses, the present study provides structural
insights into how the three loops in domain IV (see Fig. 5.3) might cooperate to expel Tc from the
ribosome: the 465-loop is responsible for distorting the backbone shape at nucleotides 1051-1054 of
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16S rRNA, which weakens or abolishes the binding of Tc at this site with the RNA; the 507-loop in the
middle of these three directly pushes Tc out of the ribosome; and the 438-loop along with nucleotide
966 and 1196 should form a corridor allowing Tc to exit.
After completion of this work, a cryo-EM reconstruction of a 70S-Tet(M) complex was pub-
lished [163]. Our results agree with the results by Wilson and coworkers in all essential details,
as expected based on the high sequence homology between Tet(O) and Tet(M).
5.4 Methods
For assessing similarity between and among the EF-G and Tet(O) families of GTPases, 313 Tet(O)
sequences were retrieved from the NCBI RefSeq database using BlastP with C. jejuni Tet(O) as the
query. 171 EF-G sequences were taken from the data set of [154] and EF-G and TetO sequences
were aligned with Mafft [164]. Consensus sequences were calculated with Consensus Finder [154].
To visualize a subset of aligned representative sequences from across the diversity of the Tet family,
phylogenetic analysis was carried out using FastTree [165].
For homology modeling, an alignment of Tet(O) with EF-G was made with 3Dcoffee [153], taking
into account the structure of Thermus thermophilis EF-G (PDB ID 2WRI [166]), for the placement
of insertions and deletions. The sequence alignment result was used to build an atomic model of
Tet(O) using Modeller [155]. This atomic model and the X-ray structure of a 70S ribosome including
a P-site tRNA (PDB codes: 2J00, 2J01 [156] ) were together fitted into the cryo-EM map by means
of MDFF [4], assuming a generalized Born implicit solvent as implemented in NAMD [6].
Experimental details of the cryo-EM and the mutation experiments are described in [8].
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Chapter 6
Dynamic behavior of trigger factor
on the ribosome
6.1 Introduction
During translation the nascent polypeptide chain emerges from the ribosomal exit tunnel and is
released into the crowded environment of the cytosol where processes such as protein folding and
targeting for translocation must occur. These processes are assisted by protein factors such as the
signal recognition particle (SRP) and its receptor (SR) in the case of targeting, and different chaperones
and chaperonins in case of protein folding. Whereas in eukaryotes a whole repertoire of chaperones
(such as RAC, NAC, SSB) interacts with the ribosome near the tunnel exit on the large ribosomal
subunit, in eubacteria trigger factor (TF) is the only chaperone, which directly interacts with the
ribosome. TF is composed of three domains: an N-terminal ribosome binding domain (RBD), the
peptidyl-prolyl cis/trans-isomerase (PPIase) domain or head domain, and the C-terminal domain
located between the RBD and PPIase domain in the TF structure and forming the arms 1 and
2 [167]. The RBD and the C-terminal domain harbor the main chaperone activity of TF, whereas
the PPIase domain is dispensable for the chaperone activity in vivo [168, 169]. Nevertheless, more
recent reports suggest that the PPIase domain provides a second chaperone interaction side for the
nascent chain at least for some proteins [170, 171]. Most of our knowledge about the involvement
of chaperones in protein folding originates from in vitro studies, where the refolding of chemically
denatured substrate proteins was monitored in the presence of chaperones with various techniques.
During recent years though, many studies have shown that in eukaryotes, as well as in prokaryotes,
protein folding starts already on the ribosome, while the C-terminal part of the polypeptide still gets
extended by the peptidyl-transferase center. Furthermore, several recent studies have shown that
the formation of secondary structures, such as α-helices, already begins within the ribosomal exit
tunnel [172, 173, 174, 175].
To date, three crystal structures of TF ribosome binding domains (RBD) in complex with 50S
ribosomal subunits (one heterologous pair of E. coli TF and archaebacterial 50 S from Haloarcula
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marismortui and two homologous pairs of TF and 50 S from Deinococcus radiodurans) have revealed
the overall positioning of the RBD on empty ribosomes [176, 177, 167]. Docking of the crystal structure
of a complete TF molecule onto the structure of the 50S associated RBD indicated that the chaperone
is localized in a position so that it “arches” over the ribosomal tunnel exit [167]. A cryo-EM structure
of E.coli ribosomes carrying a stalled nascent chain of a non-physiological substrate (SH3, which can
fold independently of TF) with a TF molecule fixed to the nascent chain via a covalent disulfide bond
in close proximity to the tunnel exit, confirmed the localization of the chaperone over the ribosomal
tunnel exit. Nevertheless, due to the limited resolution of this structure (19 A˚), the interaction of TF
with the nascent chain could not be studied in detail yet [178].
Therefore, we aimed at the visualization by cryo-EM of ribosome-bound TF when interacting
with a physiological substrate emerging from the ribosomal tunnel. For this purpose we choose the
physiological substrate galactitol-1-phosphate dehydrogenase (GatD) as nascent polypeptide chain
that is known to interact with TF and exhibits two hydrophobic stretches [171, 179].
We show, that TF interacts with ribosome nascent chain complexes (RNCs) carrying this sub-
strate with high affinity. The cryo-EM structure exhibits a high resolution for the ribosome and the
N-terminal RBD of trigger factor, whereas the middle domain and the head (PPIase) domain of TF
are less-well resolved or even non-detectable due to increasing degrees of flexibility. The resolution of
our RNC-TF-NBD map (7.7 A˚) enabled us to visualize the nascent chain within the ribosomal tunnel
and to even trace it onto the surface of the TF-RBD. We show that the two alpha helices of the
RBD undergo a conformational change when bound to the translating ribosome. This rearrangement
causes the presentation of a new hydrophobic surface on the NBD, which serves as interaction site
for the hydrophobic stretch within the emerging nascent chain. Using microscale thermophoresis we
show that the affinity of TF for RNCs increases when the nascent chain is longer that may indicate
an altered conformation of TF. We confirm this finding with a second cryo-EM structure, where TF
in complex with RNCs carrying a longer nascent chain of GatD gained rigidity partially due to addi-
tional interactions of TF with either the nascent chain or the ribosomal surface. Molecular dynamics
simulations reveal the molecular interactions between TF and the nascent chain, elucidating how the
length of the nascent chain modulates the conformation of RNC-bound TF and the binding/unbinding
of TF with RNCs.
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6.2 Results
Cryo-EM structures of TF-RNC complex
Flexibility of RNC-bound TF inferred from cryo-EM data. We generated RNCs
Figure 6.1: MDFF model of the ribosome-bound trigger fac-
tor. Densities of the EM maps for the GatD-RNC85 complex
at 7.7 A˚, 16.5 A˚ and 35 A˚ resolution are shown in (a), (b)
and (c), respectively.
carrying a GatD nascent polypeptide stalled by
the TnaC stalling sequence in vivo and subjected
these complexes to cryo-EM and single particle
analysis. A cryo-EM map of an overall resolution
of 7.7 A˚ was obtained. To our surprise this den-
sity did not account for the entire TF molecule
but rather represented only parts of the RBD of
TF. When we low pass filtered the density map
to a resolution of 16.5 A˚ the C-terminal domain
with its arms became visible (Fig. 6.1b), whereas
some densities of the PPIase domain show up
when we further low pass filtered the density map
to a resolution of 35 A˚ (Fig. 6.1c), indicating
a gradual increase in flexibility within TF from
the RBD over the C-terminal domain towards
the PPIase domain. The crystal structure of full
length TF exhibits two possible pivot points that
are likely to explain the observed flexibility. The
RBD is connected via an extended unstructured
loop (V111 to T133) with the PPIase domain.
This loop is packed against another loop con-
necting the long α-helix forming the back with
arm1 (D299 to P303). The second pivot point
could be represented by the unstructured loops
(A149 to K154 and E241 to L248) connecting the
PPIase domain with the remaining of the TF molecule. These pivot points are in agreement with our
MD simulations (see MD section).
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Figure 6.2: (a) A crystal structure of E. coli TF RBD in solution (1OMS [180]) was fitted into the EM density
and regularized using the Coot algorithm [181]. The electron density is represented as a red mesh with the ribbon
representation for the fitted model in solid red in the left panel. The middle panel shows a comparison of the crystal
structure of TF RBD in solution (1OMS, blue) with the TF RBD model fitted to the EM density (red). The right panel
shows the same comparison after rotation by 45◦ around the y-axis. (b) Surface hydrophobicity (yellow) of the fitted
TF RBD with electron density for hydrophobic stretch (yellow) and alpha helix (green) of GatD NC. (c) Comparison of
surface hydrophobicity representations of the ribosome bound TF RBD model fitted to the EM density (top) and the
TF RBD crystal structure in solution (1OMS, bottom).
Conformational rearrangement of RBD upon ribosome binding. For a molecular interpre-
tation of the density of the RBD we attempted to rigidly fit the crystal structure of E. coli TF RBD
in solution (PDB: 1OMS [180]) into the density. Even though the two characteristic α-helices (1 and
2) of the TF RBD were clearly resolved in our density map, the crystal structure did not fit well by
rigid body docking (Fig. 6.2a). To explain our density, helix 1 and helix 2 were manually adjusted by
shifts into the electron density using the Coot software [181] (Fig. 6.2a). The rearranged helices are lo-
calized directly where the hydrophobic stretch of GatD first encounters the RBD of trigger factor (see
Fig. 6.2b). The rearrangement of the two helices caused a presentation of a much larger hydrophobic
surface (see Fig. 6.2c), compared to that of the TF RBD in solution (PDB: 1OMS), favoring interac-
tions with the hydrophobic stretch of GatD. The possibility that such a rearrangement might lead to
the formation of a hydrophobic “landing surface” for the nascent chain was already suggested [177]
and is in agreement with chemical cross-link data [178].
Flexibility of TF decreases with longer nascent peptide. A recent study reported that in
vivo TF engages ribosomes stable enough for detection only after translation of about 100 amino
acids [179]. We therefore wondered whether the high degree of flexibility in our TF structure was due
to the short length of our nascent GatD chain (85 amino acids). To address this question we prepared
another sample of GatD-RNCs, where we extended the nascent chain to a total length of 145 amino
acids (GatD-RNCs145).
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First, we performed microscale thermophoresis analysis and revealed that the affinity of TF for
binding to GatD-RNC145 was fivefold higher than for binding to GatD-RNC85. Second, we determined
a second cryo-EM reconstruction of TF in complex with RNCs carrying the longer GatD145 nascent
chain at 7.8 A˚ resolution. In contrast to the first structure, more of TF was visible. Low pass filtered
maps (10.5 A˚) displayed sufficient density to accommodate full length trigger factor indicating indeed
a less flexible state of the head domain in this complex. Earlier crosslinking studies had already
shown that nascent chains of at least 90 AA length can be crosslinked to the head domain of TF [178].
Therefore, we speculated that this second GatD nascent chain would be long enough to interact with
the PPIase domain since it provides more possible interaction sites between TF and the nascent chain,
and thereby might increase the binding affinity of TF to RNC and reduce the flexibility of TF. Our
speculation is confirmed by MD simulations (see MD section).
Further sub-sorting of the EM images resulted in two sub-populations that differed in the confor-
mation of the head domain. Whereas in conformation 1 one of the arms could make a contact to helix
24 of the 23S rRNA and the head domain to helix 98 (Fig. 6.3), in conformation 2 the head domain
seems to contact helix 19 of the 23S rRNA (Fig. 6.3).
Figure 6.3: Cryo-EM reconstruction of the 70S-GatD-RNC-TF complex carrying the longer NC (filtered at 13.1 A˚ for
clarity). A molecular model (2WWQ [13]) of the 50S subunit is fitted as a ribbon representation into the electron
density map shown in grey. With the longer nascent chain, the PPIase domain of TF adopts two different conformations.
Possible contacts of trigger factor to the ribosomal 50S subunit are indicated in both conformations.
Molecular dynamics simulations of the RNC-bound trigger factor
An atomic model of the ribosome-trigger factor-nascent chain complex (Fig. 6.1) was built by applying
the molecular dynamics flexible fitting (MDFF) method [3, 4] to EM data of the GatD-RNC85 complex
(see Methods). Based on this atomic model, two smaller sub-systems were constructed for simulations
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(see Methods), one with a nascent GatD chain of 85 amino acids and one with a chain of 145 amino
acids. Four independent simulations, each 1.2 µs long, for both sub-systems were performed using
PACE, a hybrid united-atom/coarse-grained force field [182, 183, 184, 185, 186]. The simulations with
the 85-AA and the 145-AA nascent chain are referred to as the short chain simulations and the long
chain simulations, respectively.
Inter-domain motions of TF via pivot points. To characterize the motions of TF in the simu-
lations, we performed principal component analysis (PCA), using the ProDy software [187], to reveal
the dominant modes of TF motions. In the short chain simulations, the first two PCA modes represent
inter-domain motions between the RBD and the other two domains (Fig. 6.4) via the first pivot point
(residue 111 to 121). The third PCA mode captures a relative motion between the C-terminal and
the head domain (Fig. 6.4) via the second pivot point (residue 149 to 154 and residue 241 to 248).
For the long chain simulations, similar inter-domain motions via the two pivot points are observed in
the first two PCA modes (Fig. 6.4). These characteristic inter-domain motions via pivot points are in
agreement with reported MD simulations of TF monomer in solution [188, 189].
Figure 6.4: Principal component analysis of TF motions in the simulations. The top panel shows the first three
PCA modes for the short chain simulations and the bottom panel shows the first two PCA modes for the long chain
simulations. The RBD, the C-terminal domain and the head domain is colored orange, grey and red, respectively. The
blue arrows represent the motions. Only the first 500 ns of the simulations were analyzed by PCA to exclude the bound
and stable conformations. The simulations were aligned by the RBD before PCA was performed. These modes capture
the characteristic inter-domain motions of the TF via pivot points.
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Conformations of trigger factor bound with nascent chains of different length. In the short
chain simulations, the head domain of the trigger factor binds to the ribosome surface (Fig. 6.5a) within
a microsecond. The trigger factors span the ribosome surface with widespread, extended conformations
(Fig. 6.5c). The wide range of binding conformations adopted by the ribosome-bound trigger factors
in simulations agrees with EM experiments that the trigger factor bound to the 85-AA RNC is poorly
resolved beyond the RBD due to its conformational variability.
Figure 6.5: Average conformation of the trigger factor in the last 200 ns of the 85-AA chain simulations (a and c) and
the 145-AA chain simulations (b and d). Figure a and b show the side view and figure c and d show the bottom view
of the system. The trigger factor is colored blue, red, orange and yellow, respectively for each of the four simulations,
with molecular surface of the head domain shown for clarity. The ribosome is colored grey. The trigger factor is further
away from the ribosome (comparing a with b) and adopts a more compact conformation (comparing c with d) in the
145-AA chain simulations.
In contrast, the head domain of the trigger factor is further away from the ribosome (Fig. 6.5b)
in the long chain simulations. Averaged over 800 ns (last 200 ns of the four simulations), the height
of the center of mass of the head domain relative to the ribosome surface is 29.6 A˚ and 14.4 A˚ in the
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long and short chain simulations, respectively, supporting the observed lifting of the trigger factor in
the 145-AA chain simulations. Moreover, the trigger factor adopts more compact conformation in the
long chain simulations (Fig. 6.5d). The radius of gyration of the trigger factor, averaged over 800 ns
(last 200 ns of the four simulations), was determined to be: 30.6 A˚ in the long chain simulations vs.
33.6 A˚ in the short chain simulations, confirming the difference in the compactness of trigger factor
structure in the two sets of simulations. In the EM experiments, the trigger factor is better resolved
when bound with the 145-AA nascent peptide, which is consistent with the more compact structure
of the trigger factor observed in the simulations with the 145-AA chain.
We determined the percentage of time in which the C-terminal and the head domain are in contact
with the ribosome in the simulations. As shown in Table 6.1, the two TF domains (C-terminal and
Figure 6.6: Final stable conformation of TF in one of the
long chain simulations is shown (in two views) inside the
EM map of conformation 2 of the GatD-RNC145 complex
(filtered at 20 A˚). The trigger factor is colored yellow for
the RBD and the C-terminal domain and red for the head
domain. The ribosome is shown in grey with helix 19 in
blue. The proposed contact region between the head do-
main and helix 19 is circled. This TF conformation overlaps
partially with the EM densities and the head domain is in
close proximity to the proposed contact region.
head) and the ribosome are frequently in contact
in the short chain simulations. In three of the
long chain simulations, the two domains contact
the ribosome much less frequently. However in
the remaining one long chain simulation, the C-
terminal and the head domain are in contact with
the ribosome in 28.5% and 35.8% of the simula-
tion time, respectively. Moreover, the final TF
conformation in this particular simulation over-
laps indeed partially with the EM densities of the
proposed conformation 2 of the GatD-RNC145
complex (Fig. 6.6). Even though the head do-
main in this simulated conformation does not
contact helix 19 directly, it is in close proxim-
ity to the densities of the proposed contact re-
gion (Fig. 6.6). Therefore it is possible that the
head domain will reach the proposed contact re-
gion and the proposed conformation 2 will be
reproduced in the simulations if more sampling
is given.
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Table 6.1: Percentage of time in which the C-terminal domain and the head domain are in contact with the ribosome in
the simulations. A TF domain (C-terminal or head) is considered in contact with the ribosome when the heavy atoms
of the TF domain and the ribosome are within 4 A˚ in distance.
85-AA chain simulations 145-AA chain simulations
C-terminal domain - ribosome 0.2% 45.0% 6.3% 19.2% 0.0% 0.2% 0.0% 28.5%
head domain - ribosome 63.8% 31.8% 22.7% 47.2% 20.5% 8.2% 4.0% 35.8%
Interactions with the nascent peptide. In the short chain simulations, molecular contacts be-
tween the 85-AA chain and the head domain are few (Fig. 6.7a and Table 6.2), therefore the head
domain is not heavily restricted in motion by the nascent peptide and exhibits large conformational
variability. In contrast, in the long chain simulations, the N-terminus of the chain forms a “collapsed
coil” structure which establishes extensive contacts with the head domain (Fig. 6.7b and Table 6.2).
The higher binding affinity of TF to RNC with the 145-AA nascent chain observed in microscale ther-
mophoresis experiments can be attributed to the more extensive interactions between the TF head
domain and the 145-AA chain. Moreover, these interactions pull the head domain further away from
the ribosome surface and keep the head domain close to the C-terminal domain, resulting in a more
compact structure of the trigger factor.
Table 6.2: Average number of molecular contacts between the nascent chain and the head domain of the trigger factor
in the last 200 ns of the simulations. Two residues are considered in contact when their Cα atoms are within 6 A˚ in
distance. The left and right column shows the number for the four short chain simulations and the four long chain
simulations, respectively. More contacts are observed between the head domain and the 145-AA chain in the simulations.
85 AA 145 AA
13.17 29.54
13.50 25.35
5.10 33.37
0 35.86
The types of interactions between the nascent peptide and the trigger factor in the simulations
were monitored. The RBD of the trigger factor interacts with the nascent peptide mainly through
hydrophobic interactions (Fig. 6.7c and Appendix B Table B.1 and B.2), agreeing with the known
hydrophobic binding motif in the RBD [190]. Hydrophobic interactions still dominate between the
C-terminal domain and the nascent peptide, but more hydrophilic interactions arise (Fig. 6.7c and
Appendix B Table B.3 and B.4), showing that the trigger factor can interact with, and hence offer
protection to, nascent peptides of various hydrophobicity [178]. For the head domain, only a few
residues are found interacting with the nascent peptide in the 85-AA chain simulations (Appendix
B Table B.5), while much more residues interact with the 145-AA nascent chain through both hy-
drophobic and hydrophilic interactions (Fig. 6.7c and Appendix B Table B.6).
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Figure 6.7: (a) Average conformation of the N-terminus of the 85-AA nascent peptide in the last 200 ns of the simulations.
The nascent peptide is colored green and the trigger factor is colored red for the head domain and grey for the C-terminal
domain. The N-terminus of the nascent chain contacts slightly with or even detaches from the head domain of the trigger
factor. (b) Average conformation of the N-terminus of the 145-AA nascent peptide in the last 200 ns of the simulations.
The same coloring scheme as in (a) is employed. The N-terminus of the 145-AA nascent chain forms a “collapsed coil”
structure which contacts extensively with the head domain of the trigger factor. (c) Residues of trigger factor in the
ribosome binding domain (left), the C-terminal domain (middle) and the head domain (right) that interact with the
nascent peptide in the simulations are shown. These residues are shown with a VdW representation according to the
following coloring scheme: residues that participate in hydrophobic interactions with the chain are colored yellow while
residues that interact through hydrophilic interactions are colored blue, red and green for positively charged, negatively
charged and neutral amino acids, respectively.
6.3 Discussion
We employed microseconds-long MD simulations to study the dynamics of the ribosome-bound trigger
factor. Our results reveal the different conformational variability of the trigger factor when bound
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with a short and a long nascent peptide, explaining why TF is better resolved when bound with a
longer nascent chain in the EM experiments. We showcased that MD simulations can complement
cryo-EM analyses to characterize the dynamics of molecular complexes.
Moreover, this work offers insight into the chaperone function of the trigger factor. Trigger factor
functions by forming a molecular cradle over the exit of the ribosomal exit tunnel to offer protection
to the nascent peptide. We revealed that, upon binding to the ribosome, the RBD of the TF under-
goes conformational rearrangement to expose a larger hydrophobic surface for interacting with the
exiting nascent peptide. Moreover, as the nascent chain matures by elongation, the TF head domain
is capable of forming more extensive interactions with the longer nascent peptide as shown in the
simulations, explaining the higher binding affinity of TF to RNC with a longer nascent chain. These
two mechanisms enhance the TF-nascent chain interactions, and thereby, assist the recruitment of TF
to the RNC, which is essential for the chaperone function of the trigger factor.
Figure 6.8: Schematic figure illustrating how the length of the nascent peptide modulate the conformation of the trigger
factor. The ribosome is colored grey; the RBD, the C-terminal domain and the head domain of the trigger factor is
colored orange, blue and red, respectively. (A) With a short nascent chain, the head domain and the nascent chain do
not have much interactions and the head binds to the ribosome. (B) With a long nascent chain, the N-terminus of the
chain forms a “collapsed coil” structure which binds with the head domain, lifting the head domain and pulling it close
to the C-terminal domain.
TF binds to the ribosome-nascent chain complex and as elongation of the nascent peptide proceeds,
it leaves the ribosome while staying bound to the nascent peptide, allowing a next trigger factor to be
recruited to protect the elongating chain [191]. Moreover, the length of the nascent peptide has been
shown to modulate the dissociation of the trigger factor from the ribosome [192], but the molecular
mechanism is not clearly known. The simulations offer a molecular explanation: as the nascent peptide
grows longer, the trigger factor is lifted further away from the ribosome by the molecular interactions
60
between the head domain and the longer nascent peptide (see Fig. 6.8). The lifting could facilitate the
unbinding of the trigger factor from the ribosome. These interactions also serve to keep the trigger
factor bound to the nascent chain after it leaves the ribosome.
6.4 Methods
Cryo-EM and microscale thermophoresis experiments
Experimental details of the cryo-EM and the microscale thermophoresis experiments are described
in [9].
MDFF modeling
The atomic model of the ribosome-trigger factor-nascent chain complex was built in steps. First,
an atomic structure of the ribosome [13] (PDB: 2WWQ-2WWL) was flexibly fit into the ribosomal
densities of the 7.7 A˚ EM map of the GatD-RNC85 complex by the molecular dynamics flexible fitting
(MDFF) method [3, 4]. Second, the structure of the nascent chain inside the exit tunnel was modeled
with HHpred [193], and then refined by MDFF simulation with a positionally constrained ribosome.
Third, the trigger factor was modeled starting from a crystal structure of the trigger factor (PDB:
1W26 [167]), with helix 1 and 2 of the RBD rearranged by Coot as described in Results. The RBD,
the C-terminal domain and the head domain were then fitted into three EM maps of the GatD-
RNC85 complex, resolved at 7.7 A˚, 16.5 A˚ and 35 A˚ resolution, respectively, in one MDFF simulation
(Fig. 6.1). Each domain was coupled only to the respective EM map in the MDFF simulation. Since
the C-terminal and the head domain were fitted to maps of lower resolution, the secondary structure
restraints [3] applied to the C-terminal domain were twice stronger than default, and domain restraints,
which keep the backbone structure rigid during fitting, were applied to the head domain. This way
of performing MDFF, namely coupling various domains to maps of different resolutions with different
level of structural restraints, permits EM data at lower resolution to be employed for flexible fitting.
To improve the quality of the fitted models, a better solvent description, compared to that in in-vacuo
fitting [3], was furnished by the generalized Born implicit solvent model [6] in NAMD [11] during
all the MDFF simulations. All MDFF simulations were performed for 5 ns, using the same set of
parameters as employed in [6].
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Simulated systems and molecular dynamics protocols
To carry out the hybrid simulations, the nascent chain needs to be extended beyond the exit tunnel.
Without well-defined EM densities for the nascent chain outside the ribosome, an initial model of
the 85-AA nascent peptide was built by placing amino acids inside the cradle of the trigger factor
according to distance information from cross-linking experiments [178]. The chain was then subjected
to 50 ns of all-atom equilibrium simulations in implicit solvent [33], with the TF and the ribosome
constrained in positions and with harmonic distance restraints applied between the nascent chain and
the trigger factor; the distance restraints were set up based on the cross-linking experiments [178].
To extend the chain to 145 amino acids, the model of the 85-AA chain was mutated and 60 more
amino acids were added in a straight conformation to the N-terminus, followed by 50 ns of all-atom
equilibration simulations in implicit solvent [33]. Position and distance restraints similar to those
applied in the equilibration of the 85-AA chain were employed.
The two atomic models were cut smaller to reduce the simulations size by retaining only molecular
structures that are within 80 A˚ of the trigger factor. Ribosome-bound Mg2+ ions were added by the
cionize [194] plugin of VMD [116]. The sub-systems were then coarse-grained and described at hybrid
resolutions using the PACE force field [183, 195, 185]. This force field, which was developed as a
complement to the MARTINI force field [196], describes the solvent environment at a coarse-grained
level while representing proteins at a united-atom level, allowing efficient long-time simulations of
folding of several proteins into their native structures [184, 185, 186]. In the present study, the
ribosomal proteins, the trigger factor and the nascent peptide were modeled at a united-atom level.
The ribosomal RNAs were described with a coarse-grained RNA model [197] developed recently on the
basis of the MARTINI force field. The rest of the systems, including water and ions, were modeled
by means of the MARTINI force field. Each system was solvated in a 220 x 220 x 220 A˚3 water
box and buffered at 0.1 M Na+Cl− concentration. All simulations were performed in NPT ensemble
using a version of NAMD 2.9 [11] which supports the PACE force field. The following parameters
were employed in the simulations: temperature was maintained at 310 K using Langevin dynamics
with a damping constant of 0.2 ps−1; pressure was maintained at 1 atm using Nose`-Hoover Langevin
piston pressure control with a oscillation time of 100 fs and a decay time of 50 fs. the RESPA
multiple-time-stepping algorithm [81, 82] was adopted with a 4-fs integration time step, short-range
forces calculated every time step, and long-range electrostatics evaluated every time step. During the
simulations, the ribosomal RNA beads and the ribosome-bound Mg2+ ions were fixed in positions,
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which was justified as such constraints have been shown to have only a small effect on simulated
nascent chain dynamics [198, 199, 200].
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Chapter 7
Conclusions and outlook
With the continuous advance in instrumentation hardware as well as 3D image reconstruction method-
ology, cryo-EM can now routinely resolve EM structures at sub-nanometer resolution. Hybrid ap-
proaches greatly assist the interpretation of EM data by furnishing atomic models of the imaged
systems. Structure determination of macromolecular complexes is largely benefited by, and at the
same time pushes the development of, cryo-EM imaging and hybrid methods, as exemplified by the
ribosome. In this thesis works we focused on the methodological advancement of the MDFF hybrid
method and the applications to the ribosome. Structural symmetry can now be incorporated into the
MDFF protocol through symmetry-restrained MDFF [5]. Use of the generalized Born implicit solvent
model overcomes shortcomings of in vacuo MDFF simulations [6]. Participation in the Cryo-EM Mod-
eling Challenge 2010 showcased the performance of MDFF against other hybrid approaches [7]. For
applications to the ribosome, MDFF model of the Tet(O)-bound ribosomal complex revealed struc-
tural elements of Tet(O) that are critical to Tet(O)-mediated bacterial resistance to the tetracycline
antibiotic [8]. Finally a combination of MDFF and subsequent microseconds-long MD simulations
complemented a cryo-EM study about the dynamics of the ribosome-bound trigger factor [9], which
are shown to be modulated by the nascent polypeptide.
The works in this thesis indeed demonstrated several intrinsic advantages of the MDFF method.
First, the extensive set of features available in NAMD [11], the underlying simulation package of
MDFF, allows inclusion of many different forms of structural restraints into the fitting simulations.
Therefore users’ experience and knowledge about the structure can be easily and flexibly incorporated
into fitting protocol, as showcased in symmetry-restrained MDFF [5] and our participation in the
Cryo-EM Modeling Challenge 2010 [7]. Second, since MDFF is based on MD simulations, a realistic
environment can be furnished by an explicit or implicit solvent model [6], or even by a lipid mem-
brane [7], to improve the quality of fitted models. Third, as shown in the study of Tet(O)-mediated
bacterial resistance to antibiotics, homology modeling can be employed jointly with MDFF to perform
structural analyses on systems without crystallographic structures. Lastly, the readiness of MDFF
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models for further MD simulations permits the dynamics of molecular complexes be characterized by
MD in conjunction with cryo-EM analyses, as exemplified by our study of the trigger factor [9].
Looking forward, two aspects of cryo-EM modeling by MDFF should be further enhanced. First,
a closer blend between MDFF and homology modeling or structure prediction softwares is desired. As
cryo-EM imaging is continuously applied to molecular complexes of larger size, such as the recently
resolved HIV capsid structure [201], and of higher level organisms, such as the EM structure of the
human ribosome [202], it is highly likely that crystallographic structures of certain components of the
system of interest are missing. Homology modeling or structure prediction software will be needed to
provide initial structures for these components in order to perform MDFF. Therefore a good interfacing
with these softwares, or even a united algorithm combining MDFF with these softwares, will greatly
assist the use of MDFF. Second, a quantitative matching between the dynamic information extracted
from EM data and from MD simulations is of great interest. In particular, it has been proposed
that motion-affected EM densities can be interpreted in terms of MD trajectories. In the study of
the trigger factor, microseconds-long simulations provide a qualitative description of the dynamics
of the trigger factor to complement cryo-EM analyses. However with the present MD technique
and computing power, the conformational sampling achieved by MD is still insufficient to provide
a quantitative interpretation of motion-affected EM densities. In spite of that, the combination of
MDFF and subsequent MD simulations is still a promising approach to interpret dynamic information
in EM data, as MD is a natural choice to reproduce the ensemble of conformations captured in EM.
Further advance of MD methodology, such as coarse-grained MD and enhanced sampling technique,
will be needed though to resolve the sampling issue.
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Appendix A
Theoretical description of the
generalized Born implicit solvent
model
The GBIS model [86] represents polar solvent as a dielectric continuum and, accordingly, screens
electrostatic interactions between solute atoms. GBIS treats solute atoms as spheres of low protein
dielectric (p = 1), whose radius is the Bondi [203] van der Waals radius, in a continuum of high
solvent dielectric (s = 80).
The total electrostatic energy for atoms in a dielectric solvent is modeled as the sum of Coulomb
and generalized Born (GB) energies [86],
EElecT = E
Coul
T + E
GB
T . (A.1)
The total Coulomb energy for the system of atoms is the sum over pairwise Coulomb energies,
ECoulT =
∑
i
∑
j>i
ECoulij , (A.2)
where the double summation represents all unique pairs of atoms within the interaction cutoff; the
interaction cutoff for GBIS simulations is generally in the range 16-20 A˚, i.e., longer than for explicit
solvent simulations, where it is typically 8-12 A˚. The reason for the wider cutoff is that particle-mesh
Ewald summations, used to describe long-range Coulomb forces, cannot be employed for treatment of
long-range GBIS electrostatics.
The pairwise Coulomb energy, ECoulij in eq. A.2, is
ECoulij = (ke/p) qiqj/rij , (A.3)
where ke = 332 (kcal/mol)A˚/e
2 is the Coulomb constant, qi is the charge on atom i, and rij is the
distance between atoms i and j. The total GB energy for the system of atoms is the sum over pairwise
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GB energies and self-energies given by the expression
EGBT =
∑
i
∑
j>i
EGBij︸ ︷︷ ︸
pair
+
∑
i
EGBii︸ ︷︷ ︸
self
, (A.4)
where the pair-energies and self-energies are defined as [86]
EGBij = − (keDij) qiqj/fGBij . (A.5)
Here, Dij is the pairwise dielectric term [204], which contains the contribution of an implicit ion
concentration to the dielectric screening, and is expressed as
Dij = (1/p)− exp
(−κfGBij )/s , (A.6)
where κ−1 is the Debye screening length which represents the length scale over which mobile solvent
ions screen electrostatics. For an ion concentration of 0.2 M, room temperature water has a Debye
screening length of κ−1 = ∼7 A˚. fGBij is [86]
fGBij =
√
r2ij + αiαj exp
(−r2ij/4αiαj) . (A.7)
The form of the pairwise GB energy in eq. A.5 is similar to the form of the pairwise Coulomb energy
in eq. A.3, but is of opposite sign and replaces the 1/rij distance dependence by 1/f
GB
ij . The GB
energy bears a negative sign because the electrostatic screening counteracts the Coulomb interaction.
The use of fGBij , instead of rij , in eq. A.5 heavily screens the electrostatic interaction between atoms
which are either far apart or highly exposed to solvent. The more exposed an atom is to high solvent
dielectric, the more it is screened electrostatically, represented by a smaller Born radius, αi.
Accurately calculating the Born radius is central to a GBIS model as the use of perfect Born radii
allows the GBIS model to reproduce, with high accuracy, the electrostatics and solvation energies
described by the Poisson-Boltzmann equation [205], and does it much faster than a Poisson-Boltzmann
or explicit solvent treatment [206]. Different GBIS models vary in how the Born radius is calculated;
models seek to suggest computationally less expensive algorithms without undue sacrifice in accuracy.
Many GBIS models [207] calculate the Born radius by assuming atoms are spheres whose radius is
the Bondi [203] van der Waals radius and determine an atom’s exposure to solute through the sum of
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overlapping surface areas with neighboring spheres [208]. The more recent GBIS model of Onufriev,
Bashford and Case (GBOBC), applied successfully to MD of macromolecules [209, 210] and adopted
in NAMD, calculates the Born radius as
αi =
[
(1/ρi0)− (1/ρi) tanh
(
δψi − βψ2i + γψ3i
)]−1
, (A.8)
where ψi, the sum of surface area overlap with neighboring spheres, is calculated through
ψi = ρi0
∑
j
H(rij , ρi, ρj) . (A.9)
As explained in prior studies [208, 207, 210], H(rij , ρi, ρj) is the surface area overlap of two spheres
based on their relative separation, rij , and radii, ρ and ρ0; the parameters δ, β and γ in eq. A.8 have
been calculated to maximize agreement between Born radii described by eq. A.8 and those derived
from Poisson-Boltzmann electrostatics [210].
The total electrostatic force acting on an atom is the sum of Coulomb and GB forces; the net
Coulomb force on an atom is given by
~FCouli = −
∑
j
[
dECoulT /drij
]
rˆij . (A.10)
whose derivative (dECoulT /drij) is inexpensive to calculate. The required derivatives (dE
GB
T /drij) for
the GB force, however, are much more expensive to calculate because EGBij depends on interatomic
distances, rij , both directly (c.f. eqs. A.5 and A.7) and indirectly through the Born radius (c.f.
eqs. A.5, A.7, A.8 and A.9). The net GB force on an atom is given by
~FGBi = −
∑
j
[
dEGBT /drij
]
rˆij
= −
∑
j
[∑
k
∑
l>k
(∂EGBT /∂rkl)(drkl/drij) +
∑
k
(∂EGBT /∂αk)(dαk/drij)
]
rˆij
= −
∑
j
[
∂EGBT /∂rij + (∂E
GB
T /∂αi)(dαi/drij) + (∂E
GB
T /∂αj)(dαj/drij)
]
rˆij , (A.11)
with ~rij = ~rj − ~ri. The required partial derivative of EGBT with respect to a Born radius, αk, is
∂EGBT /∂αk =
∑
i
∑
j>i
[
∂EGBik /∂αk + ∂E
GB
kj /∂αk
]
+
∑
i
∂EGBii /∂αk . (A.12)
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The summations in eqs. A.9, A.11 and A.12, require three successive iterations over all pairs of atoms
for each GBIS force calculation, whereas calculating Coulomb forces for an explicit solvent simulation
requires only one such iteration over atom-pairs. Also, because of the computational complexity of the
above GBIS equations, the total cost of calculating the pairwise GBIS force between pairs of atoms
is ∼ 7× higher than the cost for the pairwise Coulomb force. For large systems and long cutoffs, the
computational expense of implicit solvent simulations can exceed that of explicit solvent simulations;
however, in this case, an effective speed-up over explicit solvent still arises due to faster conformational
exploration as illustrated in Chapter 3. The trade-off between the speed-up of implicit solvent models
and the higher accuracy of explicit solvent models is still under investigation. [206]
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Appendix B
Interactions between trigger factor
and nascent polypeptide
Residues of trigger factor that interact with the nascent peptide in the short and the long chain
simulations are listed in the six tables below. A TF residue is considered interacting with the nascent
chain if the hydrophobic/hydrophilic heavy atoms of the side chain are within 4 A˚ from that of the
nascent peptide in more than 10% of time in the last 200 ns of four simulations, i.e., more than 80 ns.
Table B.1: Residues in the RBD of the trigger factor that interact with the 85-AA nascent peptide in the short chain
simulations and the types of the interactions (hydrophobic, hydrophilic or both).
Residues Interaction types
Leu32 hydrophobic
Val35 hydrophobic
Ala36 hydrophobic
Val39 hydrophobic
Val49 hydrophobic
Pro50 hydrophobic
Met51 hydrophobic
Ile53 hydrophobic
Val54 hydrophobic
Arg57 hydrophilic
Tyr58 both
Val62 hydrophobic
Gln64 hydrophilic
Val66 hydrophobic
Leu67 hydrophobic
Met71 hydrophobic
Ser72 hydrophilic
Arg73 hydrophilic
Phe75 hydrophobic
Ile76 hydrophobic
Ile79 hydrophobic
Ile80 hydrophobic
Ile84 hydrophobic
Pro86 hydrophobic
Ala89 hydrophobic
Pro90 hydrophobic
Tyr92 hydrophobic
Val93 hydrophobic
Pro94 hydrophobic
Tyr112 both
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Table B.2: Residues in the RBD of the trigger factor that interact with the 145-AA nascent peptide in the long chain
simulations and the types of the interactions (hydrophobic, hydrophilic or both).
Residues Interaction types
Leu32 hydrophobic
Val35 hydrophobic
Ala36 hydrophobic
Ala39 hydrophobic
Ile41 hydrophobic
Phe44 hydrophobic
Val49 hydrophobic
Pro50 hydrophobic
Met51 hydrophobic
Ile53 hydrophobic
Val54 hydrophobic
Arg57 hydrophilic
Tyr58 hydrophobic
Ala60 hydrophobic
Ser61 hydrophilic
Val62 hydrophobic
Val66 hydrophobic
Met71 hydrophobic
Phe75 hydrophobic
Ile76 hydrophobic
Ile80 hydrophobic
Pro90 hydrophobic
Tyr92 hydrophobic
Val93 hydrophobic
Pro94 hydrophobic
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Table B.3: Residues in the C-terminal domain of the trigger factor that interact with the 85-AA nascent peptide in the
short chain simulations and the types of the interactions (hydrophobic, hydrophilic or both).
Residues Interaction types Residues Interaction types
Pro113 hydrophobic Glu335 hydrophilic
Gln147 hydrophilic Leu336 hydrophobic
Gln148 hydrophilic Phe337 hydrophobic
Ala149 hydrophobic Ala341 hydrophobic
Pro303 hydrophobic Arg344 hydrophilic
Ala305 hydrophobic Val345 hydrophobic
Leu306 hydrophobic Leu349 hydrophobic
Ile307 hydrophobic Leu370 hydrophobic
Glu310 hydrophilic Ile371 hydrophobic
Ile311 hydrophobic Glu373 hydrophilic
Val313 hydrophobic Met374 hydrophobic
Leu314 hydrophobic Ala377 hydrophobic
Gln317 hydrophilic Tyr378 both
Ala318 hydrophobic Pro381 hydrophobic
Ala319 hydrophobic Glu383 hydrophilic
Gln320 hydrophilic Val384 hydrophobic
Arg321 hydrophilic Ile385 hydrophobic
Phe322 hydrophobic Phe387 hydrophobic
Asn325 hydrophilic Tyr388 hydrophobic
Gln328 hydrophilic Leu394 hydrophobic
Leu330 hydrophobic Asn397 hydrophilic
Leu332 hydrophobic Met398 hydrophobic
Pro333 hydrophobic Val401 hydrophobic
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Table B.4: Residues in the C-terminal domain of the trigger factor that interact with the 145-AA nascent peptide in
the long chain simulations and the types of the interactions (hydrophobic, hydrophilic or both).
Residues Interaction types
Gln147 hydrophilic
Ser309 hydrophilic
Val313 hydrophobic
Arg316 hydrophilic
Ala319 hydrophobic
Gln320 hydrophilic
Arg321 hydrophilic
Phe322 hydrophobic
Glu326 hydrophilic
Ala329 hydrophobic
Leu330 hydrophobic
Leu332 hydrophobic
Pro333 hydrophobic
Arg334 hydrophilic
Glu335 hydrophilic
Leu336 hydrophobic
Phe337 hydrophobic
Arg344 hydrophilic
Ile371 hydrophobic
Met374 hydrophobic
Tyr378 both
Glu379 hydrophilic
Asp380 hydrophilic
Pro381 hydrophobic
Val384 hydrophobic
Ile385 hydrophobic
Phe387 hydrophobic
Tyr388 hydrophobic
Leu394 hydrophobic
Asn397 hydrophobic
Table B.5: Residues in the head domain of the trigger factor that interact with the 85-AA nascent peptide in the short
chain simulations and the types of the interactions (hydrophobic, hydrophilic or both).
Residues Interaction types
Thr150 hydrophilic
Trp151 both
Asp162 hydrophilic
Asp184 hydrophilic
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Table B.6: Residues in the head domain of the trigger factor that interact with the 145-AA nascent peptide in the long
chain simulations and the types of the interactions (hydrophobic, hydrophilic or both).
Residues Interaction types
Trp151 hydrophobic
Ile166 hydrophobic
Phe168 hydrophobic
Val172 hydrophobic
Phe177 hydrophobic
Glu178 hydrophilic
Lys181 hydrophilic
Ala182 hydrophobic
Phe185 hydrophobic
Val186 hydrophobic
Leu187 hydrophobic
Ala188 hydrophobic
Met189 hydrophobic
Arg193 hydrophilic
Met194 hydrophobic
Ile195 hydrophobic
Pro196 hydrophobic
Phe198 hydrophobic
Glu199 hydrophilic
Asp200 hydrophilic
Phe217 hydrophobic
Pro218 hydrophobic
Glu220 hydrophilic
Tyr221 both
Ala223 hydrophobic
Glu224 hydrophilic
Leu226 hydrophobic
Phe233 hydrophobic
Ile235 hydrophobic
Glu241 hydrophilic
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